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ABSTRACT
It has been well established that ischaemia can result in secondary injury to the brain 
following trauma. While such ischaemia has been imaged, it has been difficult 
demonstrate its physiological significance.
The aim of this research was to use diffusion weighted magnetic resonance imaging 
(DWI) to characterise the patterns of cytotoxic and vasogenic oedema early after head 
injury and correlate changes with regional physiology, imaged using lsO positron 
emission tomography (,sO-PET).
Data from methodological developments carried out in the course o f this research are 
presented. These include the testing of MR compatibility o f infusion pumps, 
optimisation of image processing routines, assessment of the validity of commonly used 
MR measures of tissue injury in the context of head injury, and an assessment of the 
test-retest reproducibility o f DWI.
Early DWI imaging in 30 patients with significant head injury (range 8 - 134 hours) 
revealed a characteristic contusional morphology, with a haemorrhagic core and 
concentric rings o f vasogenic and cytotoxic oedema. In the regions studied, the 
integrated volume o f pericontusional oedema was over three times the volume of the 
central core. An analysis across patients, although confounded by interindividual 
variation, suggested that this pericontusional oedema increased in size with time from 
injury. Correlation with electron microscopy suggested microvascular ischaemia as a 
mechanism for these changes
The physiological correlates of the ADC changes described above were investigated in a 
subset of nine patients with lsO-PET. The contusion core showed significant reductions 
in cerebral blood flow (CBF), oxygen extraction fraction (OEF) and cerebral oxygen 
metabolism (CMR02), while the region of vasogenic oedema only showed significantly 
reductions in CMR02. Other studies explored the use of dynamic DWI to assess the 
impact of hyperventilation on ADC changes around contusions.
The implications of these findings are discussed and further research directions 
explored.
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ADC Apparent diffusion coefficient
ASL Arterial spin labelling
CBF Cerebral blood flow
CBV Cerebral blood volume
Cl Confidence interval
CM R02 Cerebral metabolic rate for oxygen
CPP Cerebral perfusion pressure
CSF Cerebrospinal fluid
CT X-ray computed tomography
DTI Diffusion tensor imaging
DWI Diffusion weighted imaging
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FLAIR Fluid attenuated inversion recovery
GCS Glasgow coma scale
GOS Glasgow outcome scale
Hb Haemoglobin
ICP Intracranial pressure
MAP Mean arterial pressure
MR Magnetic resonance
MRI Magnetic resonance imaging
NCCU Neurosciences critical care unit
OEF Oxygen extraction fraction
,sO PET Oxygen-15 positron emission tomography
PaC02 Arterial partial pressure of carbon dioxide
Pa02 Arterial partial pressure of oxygen
PWI Perfusion weighted imaging
ROI Region of interest
Sa02 Arterial oxygen saturation
SD Standard deviation
sjo2 Jugular bulb oxygen saturation
TBI Traumatic brain injury
WBIC Wolfson brain imaging centre
Xenon CT Xenon enhanced computed tomography
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Introduction
1.1 The Problem
1.1.1 Ischaemia After Head Injury
Every year there are around 2,500 cases of severe traumatic brain injury in the UK of 
these approximately one-quarter will die and another quarter will be left with severe and 
permanent disability. Unlike injury to many other tissues, the severity of disability is not 
well predicted by the volume o f injured brain tissue. Damage to small areas in the brain 
stem or diffuse white matter tracts may lead to severe disability, while damage to a 
greater volume elsewhere may have little effect on function. The degree o f disability is 
not simply a reflection of the severity or distribution of the primary injuries but also the 
effect of secondary injuries produced by factors including ischaemia, raised intracranial 
pressure, seizures, infection, brain swelling and metabolic abnormalities. Many of these 
secondary injuries can be minimised by timely medical and surgical interventions. The 
brain is particularly vulnerable to secondary injury due to ischaemia because of its high 
metabolic rate and limited intrinsic energy stores. Indeed, post-mortem evidence after 
head injury suggests that ischaemia is a frequent cause o f secondary injury,1 and it is 
known that secondary ischemic insults such as hypotension and hypoxia can worsen 
both mortality and outcome after head injury.2 3
1.1.2 Imaging Evidence of Ischaemia
Imaging studies have demonstrated antemortem evidence of cerebral ischaemia in 
humans, particularly in the first few hours after injury. Studies using Xenon CT have 
revealed significantly reduced cerebral blood flow (CBF) in the first few hours after 
head injury,4"6 and studies using lsO-PET have shown reductions in CBF after head 
injury, associated with high regional oxygen extraction fraction, suggesting true 
ischaemia rather than hypoperfusion coupled to hypometabolism.7 Comparison of 
imaging findings to pericontusional ultrastructure suggests that at least a proportion of 
ischaemia in this setting may be the consequence of microvascular collapse due to 
extracellular oedema rather than simple hypoperfusion.5 8 9 Taken together, these studies 
demonstrate that the brain is at high risk of ischaemic damage after head injury. 
However, evidence that ischemic damage has occurred is less complete. Imaging studies 
using diffusion weighted imaging (DWI) have reported regions of reduced diffusion 
around cerebral contusions, early after head injury. These findings are typical of 
cytotoxic oedema and therefore suggest that ischemic secondary damage has occurred.10 
11 However, the associated physiology, the relationship to simple hypoperfusion and
11
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microvascular dysfunction, and the reversibility of these apparent diffusion coefficient 
(ADC) changes are unknown.
1.1.3 Defining Ischaemia
Chamber’s dictionary defines ischaemia as ‘an inadequate flow of blood to a part of the 
body, caused by blockage or constriction o f a blood vessel’. The essential part of this 
definition is the word inadequate. Although the simultaneous measurement of CBF can 
identify hypoperfusion, ischaemia can only be defined in the context of a blood flow that 
is inadequately low for tissue metabolism. The imaging of physiology associated with 
cerebral ischaemia must therefore include measurement of metabolism and CBF.
1.1.4 Imaging Options Available
The aim of this research is to characterise the patterns o f cytotoxic and vasogenic 
oedema early after head injury, correlate these changes with physiology and structure, 
and explore the dynamic nature of the changes in response to therapeutic intervention. 
The imaging o f cytotoxic and vasogenic oedema requires the use of diffusion weighted 
magnetic resonance imaging (DW MRI; DWI). However there are several techniques 
described for measuring regional CBF. These include 133Xe wash out,12 Xenon-CT,13 
MRI techniques o f dynamic susceptibility contrast and arterial spin labelling,14 and lsO 
positron emission tomography (lsO-PET). Adequate characterisation of regional 
ischaemia requires the simultaneous measurement of both regional cerebral metabolism 
and cerebral blood flow, which is only possible with 150-PET.
1.2 Overview of the Thesis
This thesis is composed of nine chapters which outline the background, methods, results 
and conclusions o f this work.
Collaborations
I was fully involved in all the studies included in this manuscript and in the 
overwhelming majority of the studies the work is entirely my own. However, this 
research was carried out in a department with an active and ongoing research interest in 
neurological injury often involving collaboration with other research groups, where such 
collaboration has occurred; I would like to describe the extent of my involvement and 
that of the other groups. In Chapters 4, 5, 6, 7 and 9 1 was assisted in obtaining the 
imaging studies by a team including radiographers, radio-chemists, physicists, nurses 
and other researchers within our research group. However for each patient included in
12
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the imaging studies I was directly responsible for some or all o f the preparation and 
imaging. I was the sole researcher conducting the image processing and analysis in these 
studies. In Chapter 5 I was the sole individual responsible for conducting these studies 
however equipment and advice was obtained from collaborators in the Department of 
Medical Physics, Addenbrooke’s Hospital, Cambridge. In Chapter 8 the electron 
microscopy studies were conducted Dr Martin Skepper in the Department of Anatomy I 
was not involved in the conduct of these EM studies. I was however involved in 
obtaining consent to research and tissue samples at the time of surgery in some of the 
patients.
Chapter 2. This chapter describes the physical principles involved in the imaging 
techniques o f MRI, with particular emphasis on DWI, and ,50-PET techniques
Chapter 3. This chapter reviews the literature pertinent to this thesis. It is presented in 
three parts which consider: the pathophysiology of head injury and secondary ischaemic 
injury, the literature on MRI (including diffusion weighted imaging) after head injury in 
experimental and clinical settings and the clinical management o f head injury.
Chapter 4. This chapter describes the methods used in these research studies, with 
particular reference to the clinical protocols used for patient management. Details of the 
MRI and PET image acquisition and image processing and analysis are presented.
Collaborations: I was assisted in obtaining these imaging sequences by a team including 
radiographers, radio-chemists, nurses and other researchers within the group. However 
for each patient included studied I was directly responsible for some or all o f the 
preparation and imaging. In the overwhelming majority of patients I was involved at 
every step o f the studies as the main researcher responsible for the patients. In all 
patients I was the sole person responsible for the off-line image processing and analysis.
Chapter 5. Methodological developments carried out in the course of this research are 
presented. The testing of the infusion pumps required for patient care in MRI is 
described. The test-retest reproducibility of the ADC values obtained in DWI is 
described. Finally this chapter underlines the importance of ADC quantification of 
diffusion by describing T2* shade back effects on DWI and ADC variability in 
pericontusional areas seen on fluid attenuated inversion recovery (FLAIR) imaging.
13
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Collaborations: I was the sole individual responsible for conducting these studies 
however equipment and advice was obtained from a collaborator in the department of 
medical physics.
Chapter 6. This chapter is concerned with the characterisation of ADC changes which 
occur early after head injury. The analysis describes the focal ADC changes around 
contusions and the ADC changes in regions of grey and white matter away from 
contusions.
Collaborations: None
Chapter 7. The physiological correlates of the focal ADC changes described in Chapter 
5 are presented in this chapter. The values of regional CBF, oxygen extraction fraction 
(OEF), cerebral blood volume (CBV) and cerebral metabolic rate for oxygen (CMR02) 
used in these analyses were derived from ,sO-PET.
Collaborations: None
Chapter 8. Describes the ultrastructural findings in pericontusional tissue. These electron 
microscopy images are related to the other imaging findings. In the discussion 
microvascular ischaemia is suggested as a mechanism which may connect these results.
Chapter 9. This chapter describes the dynamic nature o f the ADC changes around 
contusions. The effect of hyperventilation on the pericontusional ADC changes is 
explored.
Collaborations: None
Chapter 10. The conduct of the research, data analysis and results of the thesis are 
summarised.
Chapter 11. Future directions of research are discussed.
14
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2.1 MRI Physics
2.1.1 Basis of the MRI Signal
Magnetic resonance uses the signal obtained from atomic nuclei subjected to a magnetic 
field. Hydrogen nuclei are used in clinical MRI because of their abundance in human 
tissues. The property of hydrogen nuclei which produces a magnetic resonance signal is 
termed spin, and explanations of MRI often describe the nuclei as spinning bar magnets 
or gyroscopes. However, for individual nuclei, these models do not adequately describe 
the behaviour of individual spins. These spins are much better described by quantum 
mechanics. This review will use the simple “spinning magnet” models while 
acknowledging that quantum models of MRI are superior. If the reader is interested 
detailed explanations exist.15
When the hydrogen nucleus (proton) is placed in a static magnetic field, the spin vector 
of the particle (the principle axis of rotation) aligns itself with this field, this is similar to 
a compass needle aligning with the magnetic field of the Earth. These spins however 
behave like compass needles that are undamped and mounted on frictionless bearings. 
These compass needles therefore never come fully to rest but continuously oscillate 
around the direction o f the magnetic field. In magnetic resonance the oscillation is 
termed precession and the frequency of the oscillation termed the precessional 
frequency. The precession means that there is a component of the spin magnetisation 
parallel to the static field and a component which is 90 degrees (transverse) to the field. 
The parallel component of the spin magnetisation vector is termed the longitudinal 
magnetisation and the transverse component is termed the transverse magnetisation 
(figure 1)
Transverse magnetisation
Figure 1. The figure shows a spin precessing about the axis of the static field. The dotted 
circle shows the precessional path. The vector of the magnetisation has components 
longitudinal and transverse to the static field.
16
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The precessional frequency is proportional to the strength of the magnetic field and this 
can be calculated by the Larmor equation (equation 1). Energy can be imparted to the 
hydrogen nucleus if it is delivered at this precessional frequency.
co = yB
Equation 1. The Larmor equation where oo = precessional frequency (Hz), B = strength of 
the static magnetic field (Tesla) and y = gyromagnetic ratio (Hz/Tesla). The gyromagnetic 
ratio for hydrogen nuclei is 42.58 MHz/T giving precessional frequencies in the radio 
frequency range.
To generate a signal from the spins energy is delivered to the hydrogen nuclei as a 
electromagnetic pulse at the precessional frequency. This is termed a radiofrequency 
(RF) pulse since it is in the radiofrequency range. The RE pulse displaces the spins from 
their orientation in the static magnetic field. A pulse is termed a 90 degree pulse if it 
displaces the spin vector 90 degrees from the static magnetic field. When the RF pulse is 
switched off the spin vectors begin to realign with the static magnetic field. This 
realignment is associated with the recovery of longitudinal magnetisation and is termed 
T1 relaxation. Since T1 relaxation is an exponential process the T1 ‘relaxation time’ for 
a tissue is the time taken for 63% (1 -  1/e) of the T1 signal to re-develop. The initial RF 
pulse not only displaces the spins away from the static magnetic field but also causes all 
the spins to precess in-phase (in synchrony). The spins then precess about the static field 
giving rise to a RF signal, which can be detected by receiver coils in the scanner. While 
initially the spins precess in-phase, the signal begins fade. This process is termed T2 
relaxation and is due to the loss of synchrony in the spins (dephasing). The loss of 
synchrony occurs due to individual spins experiencing slightly different local magnetic 
fields. These variations in the magnetic field are due to the interaction with neighbouring 
spins. The signal emitted when the displaced spins are precessing in-phase decreases 
exponentially and the T2 ‘relaxation time’ is the time taken for 37% (1/e) of the T2 
signal to be lost. Inhomogeneities in the local magnetic field cause the T2 signal to 
decay much faster than would be expected simply from the effect of interactions with 
other spins. This ‘observed’ T2 decay is termed T2 star (T2*). However the true T2 can 
be calculated by applying a sequence of RF pulses termed a spin-echo sequence.
The values of the T1 and T2 (relaxation) time vary between tissues and these differences 
produce tissue contrast in MRI. The timing of the RF pulses and acquisition of the
17
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emitted signal can emphasise the T1 or T2 properties of the tissues, the images thus 
obtained are termed T1 or T2 weighted images respectively. However it is important to 
note that these images will contain a degree of contrast from both T1 and T2 effects (as 
well as other more subtle MRI effects). When images are produced which are weighted 
for a particular signal they are simply termed ‘images’ while when quantitative images 
of an MRI signal are created they are termed maps. For example a T1 weighted image is 
simply termed a T1 image while a quantitative map o f T1 relaxation times across the 
brain is termed a T1 map.
2.1.2 FLAIR Images
FLAIR images are obtained using an inversion recovery sequence. An inversion 
recovery sequences begin with an inversion pulse (a RF pulse which inverts the 
longitudinal magnetisation o f the spins by 180 degrees). Following the inversion pulse 
the inverted spins begin to realign with the static field. The time taken for the spins to 
realign depends on the T1 time o f the tissue. Tissues with short T1 times, such as fat, 
recover their longitudinal magnetisation fastest and tissues with long T1 times, such as 
cerebrospinal fluid (CSF), recover slowly. FLAIR is able to exploit this difference in 
recovery times to suppress signal from CSF. The FLAIR image is acquired from a spin 
echo sequence that is timed to excite the spins when the longitudinal magnetisation of 
the CSF spins are passing through zero as they realign after inversion. On FLAIR 
images therefore CSF appears black, irrespective of the contrast in other tissues. The 
exact contrast weighting of the FLAIR depends on the timing of the sequence. The 
FLAIR images used in this thesis are largely T2 weighted. FLAIR sequences are widely 
used in clinical imaging because pathology near the cortical surface or ventricles can be 
seen more easily if the signal from CSF is absent.
2.13 Diffusion Weighted MRI
Diffusion refers to the random, microscopic motion that water molecules undergo and 
which is usually called Brownian motion. During MRI this diffusion of water molecules 
causes an irreversible signal loss. While diffusion effects are present in all MRI they 
normally cause only a very little loss of signal. In diffusion weighted imaging however, 
the scan sequences are made sensitive to the signal loss due to diffusion effects. This is 
achieved by the application o f paired, pulsed magnetic gradients. These magnetic 
gradients sensitise the sequence to the effect of diffusion and allow the diffusion to be 
quantified.
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The extent of diffusion is not uniform in all brain tissue, it is restricted in some tissues 
and free (unrestricted) in others, and it is this that produces tissue contrast on DWI. 
Since diffusion causes signal loss in MRI, increased diffusion produces a dark area on 
the image. Conversely areas of reduced (restricted) diffusion cause less attenuation of 
the magnetic resonance signal leading to a brighter area. (Figure 2). The process by 
which the scan sequence quantifies diffusion involves some mathematics but is briefly 
outlined below and more fully explained in the appendix.
Figure 2. DWI shows areas of unrestricted diffusion, such as CSF filled ventricles, as dark. 
2.1.4 Principles of Diffusion Weighted MRI Sequences
If we consider the case where the diffusion gradients are applied in one direction only 
the basic principles of diffusion imaging can be understood from a simple bipolar pulsed 
gradient experiment (Figure 3). In this sequence a 90 degree excitation pulse is followed 
at time TE/2 by a 180 degree refocusing pulse. This basic spin-echo sequence is altered 
by the application of paired gradients either side of the 180 degree pulse. These paired 
‘diffusion’ gradients allow the re-phasing of signal from stationary spins whilst signal 
from moving spins (diffusion) is not rephased and the signal is therefore greatly reduced.
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Figure 3. Basic diffusion sensitised sequence. Top is a basic spin-echo, readout sequence, 
middle shows the diffusion gradients of duration 8 either side of the refocusing 180° pulse 
and separated by interval 1  The behaviour of the spins is illustrated in the lower images.
Mathematically it is possible to use this signal loss to quantify diffusion. The first 
gradient pulse induces a phase shift o f the spin transverse magnetization (T2), which 
depends on the spin position. A second gradient pulse is then applied after the 180 
degree pulse which rephases the spins. If the spins move during the interval between 
these two gradients a net dephasing will remain and this results in loss of signal. For 
static spins, (molecules which do not diffuse) the net dephasing is zero, and there is no 
signal loss. For moving spins there is a net dephasing with associated signal loss.
The diffusion can be calculated from the degree of signal loss according to the Stejskal- 
Tanner equation. This is based on the work of EO Stejskal and JE Tanner and forms the 
basis of diffusion imaging.16 The derivation of the equation is covered in the appendix.
S = S0e~bD
Equation 2. The Stejskal-Tanner equation. S denotes the signal from a voxel, So the signal 
without diffusion gradients, b is a constant which summarises the duration and strength of 
the diffusion gradients, D is the diffusion coefficient (which has dimensions of length2.time'1, 
usually given as mm2/sec)
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The b value for a particular sequence summarises the strength and duration of the 
diffusion gradients. It is given by equation 3.
b = r 2G2S 2 A
Equation 3. y  denotes the gyromagnetic ratio, G the gradient strength, b the gradient 
duration, A the time interval between the pulses.
The total distance covered by water molecules taking the “random walk” of diffusion is 
greater than the apparent distance that they have moved in a given time. To emphasise 
this point the maps of mean diffusion (D) are tam ed apparent diffusion coefficient 
(ADC) maps. It is important to understand the difference between DWI and ADC maps. 
Firstly image contrast seen on DWI images are typically reversed on ADC maps. Thus 
restricted diffusion is seen as dark regions on ADC maps and areas of higher diffusion 
(such as vasogenic oedema) are seen as bright regions. Secondly the signal on DWI 
represents several magnetic resonance effects, for example T2, T2* and T1 effects, in 
addition to the effect of diffusion. ADC maps however are specific to the effects of 
diffusion. Therefore to quantify diffusion and eliminate other MRI effects it is useful to 
construct ADC maps. ADC maps are created by solving the Stejskal-Tanner equation 
(Equation 2) for D at each image voxel.
‘Normal’ ADC Values in the Brain after Head Injury imaged at Three Tesla 
The diffusion of water in the brain varies according to the type of brain tissue, CSF has a 
high ADC value (around 25 x 10"* mm2/sec), highly structured white matter such as the 
corpus callosum has low ADC values (around 3 x1c4 mm2/sec) and grey matter has 
intermediate ADC values (around 6-9 x 10"* mm2/sec). ADC values in brain tissues are 
similar in both hemispheres, and between men and women. They do not vary 
significantly with age in adult life however young children are known to have higher 
ADC values.
Typical adult ADC values in a range of brain tissues are shown in the table below.
Tissue Average ADC (mm2/sec)
Cortical grey matter 7 - 9  x 10"*
Deep grey matter 6 -7x10"*
Mixed white matter 4 -6 x 1 0 " *
Corpus callosum 3-4x10"*
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The diffusion of water within a tissue type also varies according to proportion of 
intracellular and extracellular fluid. Water molecules in the intracellular fluid are 
relatively restricted in their diffusion due to interaction with intracellular proteins and 
other structures. Conversely, when water is in the extracellular fluid compartment its 
diffusion is relatively free. This difference in the diffusivity of water within different 
physiological compartments provides insight in to the relative amounts of fluid in these 
two tissue compartments. This allows ADC changes to demonstrate the formation of 
intracellular (cytotoxic) oedema and extracellular (vasogenic) oedema after CNS injury.
Anisotropy
The diffusion within tissues may not be equal in all directions (isotropic); this preference 
for diffusion in one direction is termed anisotropy. Anisotropy arises from the presence 
of cellular and extracellular structures. This is most clearly illustrated in white matter 
where myelinated fibre tracts allow more diffusion parallel to the fibre tracts than across 
them (as shown in figure 4).
Transverse
Diffusion
A
Figure 4. Directionality of diffusion. The figure shows three parallel myelinated nerve fibres 
and the effect of the fibre orientation on the directionality of diffusion. The fibres allow 
relatively free diffusion parallel to their main axis, however transverse diffusion is 
restricted by the fibre tracts.
This directionality of diffusion can be measured during diffusion MRI by applying the 
diffusion gradients in a number of directions. The directional anisotropy in a tissue 
cannot be adequately described by a scalar measure such as ADC but is better described
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by a 3x3 tensor matrix. Where each element represents the diffusion in a particular 
direction. The 3x3 tensor can be visualised as a three dimensional ellipsoid shape, 
termed a diffusion tensor (figure 5).
Figure 5. A diffusion tensor ellipsoid. Arrows represent the three principal Eigen vectors 
(XI, X2, and X3)
The diffusion along the three principal axes of the tensor are termed the Eigen values of 
diffusion; which can be used to summarize the degree of anisotropy. The fractional 
anisotropy (FA) is a summary measure of the degree to which the three Eigen values 
differ. An FA of 0 describes isotropy (a spherical tensor) and an FA of 1 describes 
complete anisotropy (an infinitely long tube). Biological tissue has FA values between 0 
and 1 which can be represented as ellipsoids of various shapes. FA maps show areas of 
highly directional diffusion as high intensity (figure 6). The equation for FA is given in 
the appendix.
Figure 6. FA map showing areas of high anisotropy (directional diffusion), such as white 
matter tracts, as hyperintense.
These FA maps were only used in this research to identify areas of grey and white 
matter during image analysis.
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2.2 PET Physics
The use of positron emitting isotopes, incorporated into biological tracers, has enabled 
in-vivo studies of human physiology in health and disease. In the case of lsO-PET the 
administration of 15C>2 , ClsO and H2lsO permits the quantification of regional CBF,
CBV, CMRO2 and OEF. lsO has a half-life o f 123 seconds and in its decay emits a 
neutrino (a very weakly interacting particle) and a positron. The positron travels a short 
distance in tissue before it annihilates with an electron. The energy of annihilation 
produces two photons, each with an energy of 511 keV at 180° to each other.
The paired photons can be detected by the cylindrical array of detectors in the PET 
scanner and converted into an electrical signal. Tomographic image reconstruction is 
then used to recover the three-dimensional tracer distribution. The in-plane resolution of 
the technique, on our scanning system, is 6.7 mm, but the low signal to noise ratio of the 
images necessitates the application o f a degree of spatial smoothing such that the 
effective in plane resolution is 7.8 mm.
CEREBRAL BLOOD VOLUME
The avid binding o f carbon monoxide to haemoglobin allows C lsO to be used as a tracer 
for the measurement of CBV. The patient inhales a small quantity o f C lsO and 60 
seconds lata*, after carboxyhaemoglobin has equilibrated throughout the blood volume, 
emission data are collected for five minutes. During this time blood samples are taken to 
quantify the activity in the peripheral blood. iCBV is calculated according to equation 4:
rCBV = C(issue
Cblood X ^
Equation 4. Ctjmt is the tissue radioactivity measured by the scanner, CMood is the 
radioactivity measured in the peripheral blood, R is the ratio of the cerebral to peripheral 
blood haematocrit This value is usually assumed to be 0.85 ml/lOOg of brain tissue,1718 but 
it should be noted that this assumed value of R is unlikely to hold true for all tissues. It may, 
in particular, cause underestimates of CBV where blood flow is high, this is discussed below 
(Section 2.2.1).
CEREBRAL BLOOD FLOW
The steady state method of determining CBF is best suited to studying CBF after head 
injury since it is accurate in the low CBF range. H2lsO is administered as a constant 
intravenous infusion, and after a build up period of 10 minutes a stable level of activity
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is achieved, during which two five minute emission frames are obtained. rCBF is 
calculated from the following equation:19
blood.
tissue
Equation 5. CtfBII( is the tissue radioactivity measured by the scanner, CMood is the 
radioactivity measured in the peripheral blood, a  is the decay constant for lsO 
(In2/T1/2=0.00564 seconds'1), X is the blood-brain partition coefficient for water.
The model assumes a linear relationship between tissue radioactivity and rCBF. 
However this relationship does not hold at high CBF values and high CBF values (even 
in some areas of normal grey matter) may be underestimates. The model assumes a 
value for X of 0.95 across the whole brain, yet values for X differ in white and grey 
matter. These two problems mean that rCBF values in mixed grey-white matter may be 
underestimated by up to 20%.20
CEREBRAL OXYGEN METABOLISM
Regional measurements of OEF and CMRO2 are obtained following a steady-state 
inhalation of 150 2. Trace amounts of labelled ,50 2 are inhaled in air for 10 minutes and 
emission data are collected while the inhalation is continued for a further 10 minutes. In 
essence the calculation relies upon the equation
O metabolised by the tissueOEF = —r5— ---------------- ---------------
„  ^ ,  O delivered to the tissueEquation 6
However there are three sources of lsO activity during the scan: 150 2 metabolised by the 
tissue and converted to H2lsO, 150 2 in arterial blood, and H2lsO produced in the tissues, 
which re-circulates during the scan. In addition, a significant amount o f unextracted 150 2 
is present in the venous blood and a correction for rCBV must be made.
Therefore data from three scans must be available to determine rOEF, along with 
arterial and plasma samples which are required to measure 150 2 bound to haemoglobin 
and H2lsO in plasma and blood. The equation for rOEF' (OEF uncorrected for CBV) is 
shown (equation 7):19 21
25
Physical Principles of the Imaging Techniques
f cf, a  c  , ,h ? o )tissue ! y arterial 2 Ca rte ria l^2®
c„ h , o  c , a,\ tissue 2 plasma 2 J p la sm a ^2 ®  j
C grteria lQ  ^ a r te r ia l^ 2 ®
CpiasmaO2 C p la sm a ^ 2 ®
Equation 7. Cdint02 is the tissue activity during the steady state IS0 2 inhalation, Ctis$ueH20  
is the tissue activity during the steady state H2lsO infusion, CarteHaiH20  is the whole blood 
activity during the steady state H2lsO infusion, Cr.— O? is the plasma activity during the 
steady state ls0 2 inhalation, Cp|MnuH20  is the plasma activity during the steady state H2lsO 
infusion, Carteri*i02 is the whole blood activity during the steady state 1S0 2 inhalation
As a significant component of the measured tissue radioactivity is related to the 
intravascular 150 2 that has not been extracted and to avoid overestimating OEF it is 
necessary to correct for this using an independent measurement of the CBV. The 
corrected value for OEF is calculated using equation S.22
Equation 8
where X  is given by:
rCBF/100 + 6(U 
~rCBF(rCBV) + 6(U
Equation 9. X is the blood-brain partition coefficient for water.
CEREBRAL OXYGEN METABOLISM 
Finally, CM R02 can be derived from the following relationship:
rCMR02 = rOEF x rCBF x Ca0 2
Equation 10. Ca02 is the Mood oxygen content ip pmol/lOOml
r O E F ^ r O E F ' - X
l - X
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Figure 7. PET scanner with the cover removed to demonstrate the cylindrical array of 
detectors and photomultipliers. The patient couch (seen at the bottom of the picture) is 
moved into the bore during scanning however all other parts are static.
2.2.1 Assumptions and limitations of the oxygen-15 steady-state model
The steady-state ,sO PET technique is considered the optimum clinical method for 
measurement of rCBF. However it has some limitations, which are important to 
consider.
1. The model assumes uniform values for the partition coefficient of water (A.) and for 
the cerebral to peripheral haematocrit ratio (R); assumptions which may be especially 
invalid in the injured brain and which produce underestimates of high CBF values.
2. A complete PET dataset of the three scans (15C>2, H2lsO and ClsO) requires 
approximately 60 to 90 minutes to obtain; during which time, even with careful clinical 
care, physiological parameters such as intracranial pressure (ICP), cerebral perfusion 
pressure (CPP), PaC02 may change.
3. Whilst better than some other techniques, the spatial resolution of PET scans is such 
that small areas of damage may be difficult to perceive.
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3 Review of the Literature
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3.1 Cerebrovascular Physiology & Pathophysiology
3.1.1 Cerebral Ischaemia - Cerebral Energy Requirements
Overall, the brain receives a blood flow of around 50ml/100g/min. More metabolically 
active tissue such as grey matter receives around 70ml/100g/min, while white matter 
receives around 20ml/100g/min. This large cerebral blood flow is necessary because the 
brain is the most metabolically active tissue in the body. While it makes up only 2% of 
body weight, the brain’s energy consumption accounts for 25% of the total body glucose 
utilisation. This glucose is metabolised in the brain to produce ATP which provides 
energy to support the structure of the cells, drive axonal flow, and synthesise, package, 
release and reuptake neurotransmitters. However the process with the greatest energy 
consumption is the maintenance of the transmembrane ionic gradients by ionic pumps 
(accounting for around 70% of the brains ATP usage). Without this essential process the 
propagation o f nerve action potentials within the brain would fail.23
3.1.2 Insights into Ischaemia from Stroke Research
Before discussing the literature relevant to ischaemia after head injury it is worth 
reviewing the data from stroke. In acute stroke there is an abrupt cessation of arterial 
supply, typically due to arterial thrombosis or embolism, to a region of metabolically 
normal brain. It is therefore the simplest example of cerebral ischaemia, and it has been 
extensively studied in animals and humans. The process of secondary ischaemia after 
head injury differs from acute stroke. For example, there is significant suppression of 
cerebral metabolism after head injury, and the mechanisms by which perfusion is 
compromised often occur more gradually, which may allow the brain to tolerate 
ischaemia better. Despite these differences the mechanisms of ischaemia are likely to 
have some commonality. Stroke therefore provides a useful background against which 
ischaemia after head injury may be considered.
The high metabolic demand and limited energy reserves of the brain mean that when 
ischaemia occurs, tissue energy demands cannot be met and cellular ATP levels fall. 
This is typified by acute ischemic stroke, where the reduction in ATP results in 
decreased function of ion pumps, sifch as Na-K-ATPase, which uses ATP to maintain 
high intracellular concentrations o f K+ and low intracellular concentrations o f Na+. 
Efflux o f K+ from neurons results in prolonged elevations in extracellular K+ and 
massive cellular depolarization.24 Other cellular ion gradients are also lost; intracellular 
Na+ and Ca2+ rise and intracellular Mg2+ falls. Extracellular concentrations of many
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neurotransmitters are increased during ischemic stroke. Entry of Ca2+ via voltage 
sensitive Ca2+ channels stimulates release of vesicular neurotransmitter pools, including 
the excitatory amino acid neurotransmitter glutamate. At the same time, Na+ dependent 
reuptake of glutamate is impaired by the loss of transmembrane ion gradients. Thus, 
both impaired glutamate uptake and enhanced glutamate release contribute to sustained 
elevations of extracellular glutamate in the ischemic brain.25 This excess glutamate leads 
to further damaging ionic and biochemical changes, a process known as excitotoxicity. 
In addition to the changes at the cell membrane, the fall in pC>2 during ischaemia leads to 
a lactic acidosis as cells undergo a shift from aerobic metabolism to anaerobic 
glycolysis, which decreases the pH of the ischemic tissue from the normal 7.3 to around 
6.5.
These data from ischemic stroke research provide insights into how physiology and 
biochemistry interact to modify ischemic brain injury. While ischaemia arises from an 
inadequate supply of oxygenated blood to the tissue (or an inability of the tissues to use 
the available blood supply) there are different tissue susceptibilities to ischaemia. Even 
cells o f the same type lying side by side in the brain, can display different vulnerabilities 
to equivalent degrees of ischaemia. This variable vulnerability to ischaemia coupled 
with the ability of tissue near the periphery of the ischemic region to maintain some 
blood supply from neighbouring vascular territories, lead to the concepts of stroke ‘core’ 
and ‘penumbra’.26 The core of the ischemic area of brain undergoes rapid and 
irreversible ischemic damage, while the penumbra, which is either less susceptible to 
ischaemia or is able to maintain some blood supply, is functionally impaired but remains 
viable. The exact physiological and radiological definitions of these two regions after 
stroke remain a subject of debate.27'34
CLINICAL RELEVANCE OF THE PENUMBRA
Clinically, the penumbra can be thought of as the tissue which is threatened but which 
can be salvaged by therapeutic intervention. Imaging such as computed tomography 
(CT), PET and MRI have been used both as research techniques and clinical tools to 
assess the extent of damaged and hypoperfused brain following stroke and to select 
patients for thrombolysis.35 Conventional CT cannot reliably distinguish the ischemic 
penumbra.3637 However, CT techniques, such as perfusion contrast CT contrast and Xe- 
CT, are able to define the tissue at risk and hold clinical promise.38 39 0 ,5-PET can 
quantify regional CBF, CMRO2, OEF and CBV, and by relating blood flow and 
metabolism, is able to define ischemic tissue based on physiological thresholds.40 
However, 0 15-PET is an expensive, specialised technique, and is not widely available,
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and therefore generally remains a research technique. MRI techniques, particularly DWI 
and perfusion weighted MRI (PWI) are widely used imaging techniques after ischemic 
stroke. The acute DWI changes following stroke are temporally related to run down of 
ATP,4142 and reflect the development of cytotoxic oedema, as the transmembrane ionic 
gradients are lost and the cells swell.43 While the early DWI changes following stroke 
have been shown to be reversible in some studies,44 45 increased intensity on DWI is 
generally thought to be an early and useful marker of local cytotoxic oedema. These 
changes after stroke usually evolve over a characteristic time course.4647
Even when these changes are reversible, it is clear that they represent tissue which is 
under a significant ischaemic burden, and selective neuronal loss or secondary imaging 
changes occur even if the initial DWI abnormality is reversible.33 48 The DWI-PWI 
mismatch is the area of reduced perfusion seen on PWI which lies outside the DWI 
abnormality. This represents the hypoperfused penumbral tissue following stroke; this 
tissue is the main target of thrombolysis and the paired techniques of DWI-PWI are still 
of great practical use when selecting patients for thrombolysis.2849
In summary, there are differences in the pathophysiology of head injury and ischemic 
stroke, which mean that the process o f ischemic damage after stroke may not be a fully 
acceptable paradigm for ischaemia after head injury. However, both stroke and ischemic 
damage following head injury share some commonality in their pathophysiology50-52 and 
MRI imaging findings.53 This has lead to the concept of a traumatic penumbra following 
head injury which is similar to the ischemic penumbra after stroke.54 55 A better 
understanding of the MR imaging appearances following head injury may be facilitated 
by a description the mechanics and pathophysiology of head injury. This is therefore 
reviewed below.
3.2 Mechanics and Pathophysiology of Head Injury
The severity and type of impact occurring during head injury will substantially influence 
the structural lesions that ensue (Figure 8).
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Figure 8. Biomechanics of head injury. Diagrammatic representation of the duration and 
intensity of acceleration-deceleration insult on the type of injury produced. (Redrawn from 
Bullock, 1997).
The acceleration-deceleration forces that ensue from impact during falls and motor 
vehicle accidents can produce axonal dysfunction and injury, brain contusions, and axial 
and extra-axial haematomas. The generation of such macroscopic injury is associated 
with microscopic and ultramicroscopic changes, including ischaemic cytotoxic oedema, 
astrocyte swelling with microvascular effacement and dysfunction, microglial activation 
and recruitment, blood brain barrier disruption with vasogenic oedema, and phasic 
inflammatory cell recruitment.56
These varied pathophysiological consequences of a single structural pathology are well 
reflected by sequential changes in cerebrovascular physiology that are observed 
following head injury. Classically, cerebral blood flow (CBF) is thought to show 
triphasic behaviour57 58 (Figure 9). Early after head injury (within 12 hours), global CBF 
is reduced, sometimes to ischaemic levels. Between 12 and 24 hours post injury, 
gradually CBF increases towards baseline levels, and the brain may exhibit supranormal 
CBF two to five days post injury. While many reports refer to this phenomenon as 
hyperaemia, the absence of consistent reductions in cerebral oxygen extraction suggest 
that metabolism and blood flow often remain coupled, and a more appropriate label is 
coupled hyperperfusion. CBF values begin to fall several days following head injury, 
and in some patients these reductions in CBF may be associated with marked increases 
in large vessel flow velocity on transcranial Doppler ultrasound that suggest vasospasm.
These time-varying haemodynamic responses also define the vascular contribution to 
ICP elevation in time. Immediately after head injury there is no vascular engorgement,
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and though a transient blood brain barrier (BBB) leak has been reported in the first hour 
after impact in animal models, there are no data regarding BBB disruption at this stage 
in humans. Apart from mass lesions (e.g. intracranial haematomas), ICP elevation during 
this phase is assumed to be the consequence of cytotoxic oedema, usually secondary to 
cerebral ischaemia. Increases in CBF and cerebral blood volume (CBV) from the second 
day post-injury onwards make vascular engorgement an important contributor to 
intracranial hypertension.
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Figure 9. Pathophysiology of brain water and CBF. Diagrammatic representation of 
changes in brain water, average ADC, and CBF, and the associated physiological processes 
responsible for intracranial hypertension at various points following head injury. The 
temporal patterns of the various processes depicted are based on a consensus for both 
clinical and experimental literature cited in this chapter.
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Following a transient initial dysfunction, the BBB appears to become leaky between the 
second and fifth days post-trauma, and vasogenic oedema then contributes more to brain 
swelling. It is important to recognise that brain water is increased within the first hour 
following injury, and remains high for up to two weeks (Figure 9). Over this period the 
excess brain water probably redistributes to varying extents between the intra- and extra­
cellular compartment. In the setting of ischaemic stroke, early intracellular oedema is 
usually referred to as “cytotoxic”, and often attributed to neuronal ischaemia. The 
situation in head injury is more complex. Cell swelling may involve astrocytes and be 
the consequence of glutamate reuptake rather than the direct consequence of ischaemia. 
Alternatively, the extracellular oedema that accumulates following brain trauma may be 
protein rich and restrict the diffusion of extracellular water,58 endowing it with attributes 
that result in MR appearances that are conventionally associated with intracellular 
oedema. Finally, the cell swelling and extracellular oedema may result in micro vascular 
injury and collapse,59 60 and be the cause, rather than the consequence of ischaemia 
(figure 10).
Figure 10. Macrovascular and microvascular ischaemia. Conventionally, reductions in 
cerebral perfusion are due to reductions in cerebral perfusion pressure or obstruction of 
proximal conductance vessels. This results in relatively uniform ischaemia in the territory 
of the vessel involved, and greater oxygen extraction (B) when compared to the normal 
setting (A). However, microvascular injury associated with head trauma can cause 
astrocyte swelling, perivascular oedema, endothelial swelling, and microvascular collapse 
(D). This results in tissue hypoxia with heterogeneous patterns of ischaemia and oxygen 
extraction (C).
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While ischaemia is common at postmortem in fatal head injury,1 CBF reductions are 
generally modest in the first few days following injury. Two different factors may 
provide explanations for this discordance. First, ischaemia may be an ultra-early event 
(<12 hours),61 and may be missed by many clinical studies, which are commonly 
undertaken at later time points. Second, there may be substantial pathophysiological 
heterogeneity in the injured brain, and the impact of regional critical ischaemia at later 
time points may be diluted by surrounding normal tissue, with no significant net effect 
on global measures of CBF.62 Since structural changes, as detected by CT or 
conventional MRI, are likely to be relatively late and irreversible, these considerations 
have lead to the conclusion that there is a need to image physiology and metabolism in 
such patients.
The best established technique for physiological imaging is the use o f stable Xenon CT 
studies for measurement of rCBF. While perfusion imaging confirms the presence of 
regional hypoperfusion in head injury, interpretation of these findings is confounded by 
the fact that metabolism is independently depressed in head injury, and the CBF 
decreases may represent appropriately coupled hypoperfusion rather than ischaemia 
(Figure 4). Concordant imaging of both flow and metabolism can address this issue, but 
this approach requires lsO-PET, which is not widely available. There has therefore been 
interest in DWI after head injury, in the hope DWI may be able to image the 
consequences o f ischaemia, if  not ischaemia itself. In addition, the use of MRI raises the 
possibility that it may be possible to image regional cerebral perfusion within the same 
modality (using DSC or arterial spin labelling) although the validity of absolute CBF 
values obtained using these MRI techniques remains unclear. MRI cannot (at present) 
measure cerebral metabolism or oxygen extraction, however such measurements are 
necessary to adequately define ischaemia (Figure 11).
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Figure 11. Conceptual paradigms in cerebral ischaemia. Conventionally, hypoperfusion is 
thought to represent ischaemia, and hyperperfusion, hyperaemia. However, these 
definitions are no longer valid when there are independent changes in cerebral metabolic 
rate (MET), as have been shown in head injury. In these settings, ischaemia can only be 
defined by documenting an increase in oxygen extraction fraction (OEF), or by showing 
that CBF reductions produce cytotoxic oedema.
3.2.1 Insights from MRI in Experimental Models of Head Injury
A variety of animal models have been used to mimic human head injury. While the 
details of these models are covered in other publications, it is important to recognise that 
none of these covers the entire spectrum of pathology observed in humans. Broadly 
speaking, the controlled cortical impact model primarily produces a focal cortical 
contusion with some deeper injury, while the impact acceleration model is similar but 
produces a greater degree of acceleration-deceleration insult, and may produce more 
axonal shearing. The lateral fluid percussion injury produces a more widespread and 
diffuse injury over the injured hemisphere, and also results in transmitted pressure wave 
through the brain. Other models mimic subdural and epidural haematomas, but DWI 
studies of these models are limited.
3.2.2 DWI Changes after Experimental Head Injury
Despite the important role ascribed to cerebral ischaemia in the context of head injury, 
early MRI studies with diffusion-weighted imaging suggested that the pathophysiology 
in animal models of head trauma was significantly different from that seen in simple 
ischaemia. Hanstock et al63 showed that within the first four hours post injury, rats 
subjected to a moderate fluid percussion injury showed increases, rather than decreases 
in ADC, contrary to the findings in acute ischaemic stroke. These data suggested early 
vasogenic oedema, and were concordant with previous studies that had demonstrated 
early opening of the blood brain barrier using a variety of techniques, including Evans 
blue extravasation64 and Gd-DTPA enhancement on MR imaging.65
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More recent data from an impact-acceleration model suggest that this early increase in 
ADC is a real and consistent finding in a context that mimics contusion in human head 
injury.65 66 However, it has become clear that this initial phase of high ADC (which 
implies vasogenic oedema) is rapidly succeeded by a prolonged phase o f low ADC, 
which lasts up to two weeks following injury.66 The initial increases in ADC are 
consistently associated with increases in T2, demonstrated on T2 weighted spin echo or 
fluid attenuation inversion recovery (FLAIR) MRI sequences, appearances which 
characterise vasogenic oedema. At least at early stages, the ADC increases are also 
temporally concordant with increased BBB leak as demonstrated by local enhancement 
following administration of Gd-DTPA.65 Interestingly, both the early increases in ADC, 
and the subsequent reductions in ADC occur against a background of increased brain 
water content, which may only be small (a rise from 79% to 81%), but is clearly 
associated with disruption of normal physiology and characteristic imaging findings.66 
The severity of ADC reduction in such models may be substantially enhanced by 
hypotension and hypoxia, which add physiological insults to the picture produced by 
traumatic injury.67 The detection and temporal patterns of the high and low ADC phases 
is also crucially dependent on the precise model used, the severity of insult, and the time 
points at which imaging is undertaken. Consequently, departures from this pattern have 
been reported by other authors,68'70 who have used somewhat different methodology. 
ADC reductions, which are usually interpreted as signifying ischaemic cytotoxic 
oedema, are not confined to contusion models. Other studies, in models of experimental 
subdural haematoma, show reductions in ADC values in underlying cortex by one hour 
post insult, which become more extensive over the following two hours.71
3.23  PWI Changes in Experimental Head Injury
Perfusion weighted imaging in experimental models of head injury has employed both 
susceptibility contrast agents69 72 and arterial spin labelling (ASL) techniques.73 In 
summary, these studies show significant reductions in relative CBF (rCBF) and CBV 
(rCBV). Significantly, early PWI (performed one to three hours post injury) showed far 
more severe and widespread perfusion deficits when compared to imaging studies that 
were undertaken 24 hours post head injury.73 These studies also confirm the perfusion 
heterogeneity in the injured brain, both at early and late time points, and demonstrate 
pericontusional hypoperfusion,69 73 the severity of which correlates with early reductions 
in regional ADC. However, the extent of subsequent histological injury is better 
reflected by the extent of ADC change, rather than the perfusion deficit, which is 
typically much larger.69 One important methodological finding is the observed
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heterogeneity in T1 values across the injured brain,73 which results in marked 
inaccuracies in calculated CBF with ASL techniques, if normal T1 values are used.
3.2.4 Interpretation of Experimental MRI Data
While these data provide important pointers to understanding the imaging findings on 
diffusion weighted MRI in humans, they possess two major shortcomings. First, no data 
are available from animal studies that clearly delineate DWI responses in diffuse axonal 
injury, since experimental models of this pathology are less well developed and 
characterised. This is a major failing since axonal shearing is an important pathological 
finding and prognostically relevant lesion in human head injury. Second, human head 
injury often combines several lesions including contusions, extra-axial haematomas, and 
axonal shearing injury, and although some MR studies have attempted to address this 
issue,74 the models used may not be representative, and the effect of interaction of these 
varying pathologies on imaging appearances remains unclear.
3.2.5 Acute MRI in Clinical Head Injury -  DWI Detection of Cytotoxic Oedema
Early MR studies of head injured humans used conventional sequences to demonstrate 
the sensitivity of the technique for detecting axonal injury, with demonstration of 
patterns of pathology that had major prognostic significance.75 Subsequently several 
authors showed that DWI revealed lesions that were in keeping with axonal shearing 
injury, days to months following head injury.76'80 In some o f these instances, 
conventional MRI was entirely normal.79 Several of these studies showed major 
reductions in regional anisotropy on diffusion tensor images (DTI), particularly in 
subcortical white matter in the frontal and temporal regions, and in the splenium of the 
corpus callosum, all of which are classical sites of diffuse axonal injury. The sensitivity 
of DWI and DTI in demonstrating these lesions was significant, and they were thought 
to represent loss of water anisotropy in sheared white matter tracts. However, increases 
in signal intensity on DWI images were seen as early as one day post injury77 81 and were 
seen to be transient in other studies,7881 this pattern o f DWI hyperintensity may 
represent cytotoxic oedema. Clearly the interpretation of some early studies remains 
difficult as ADC values were not reported, and the coexistence of T2 changes made it 
difficult to exclude the presence of T2 “shine through” in DWI images with significant 
T2 weighting.
3.2.6 MRI in Acute Head Injury -  DWI Detection of Vasogenic Oedema
A framework for classifying changes on DWI images has been suggested by Hergan et 
al,82 who classified lesions based on DWI and ADC appearances:
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Type 1 Lesions are DWI and ADC hyperintense.
Representing vasogenic oedema, with the DWI hyperintensity arising
from T2 shine through effects.
Type 2 Lesions are DWI hyperintense and ADC hypointense
Representing cytotoxic oedema
Type 3 Lesions have a haemorrhagic core surrounded ADC hyperintensity.
Representing core and pericontusional vasogenic oedema
In addition, all scans were classified into three groups based on the size and extent of 
lesions, with group A consisting o f focal injury, group B consisting of regional or 
confluent focal injuries and group C representing diffuse or extensive injury.
3.2.7 MRI in Acute Head Injury -  Complex DWI Changes
While the classification suggested by Hergan may be useful, it is not yet widely used 
and may represent an oversimplification. For example, a narrow rim of low ADC just 
outside regions of pericontusional vasogenic oedema has been reported by some 
authors.1011 These findings are reminiscent of low ADC cuffs seen around intracerebral 
haemorrhage in some patients.83 ADC reductions are typical o f tissue ischaemia and 
whether this rim of reduced ADC around the contusions represents tissue ischaemia is 
unknown.
3.2.8 MRI in Acute Head Injury -  DWI Detection of Axonal Injury
As described in section 3.2.4 the techniques of DWI and DTI possess great sensitivity in 
detecting axonal injury.84 The burden of axonal injury is often best appreciated on 
fractional anisotropy (FA) maps, which provide a quantitative measure of the anisotropy 
within an imaging voxel (figure 12). The presence of intact myelinated white matter 
tracts results in marked anisotropy, and FA maps clearly show the white matter 
pathways in the brain. While T2* weighted gradient echo images may be more sensitive 
at detecting the microhaemorrhages associated with axonal injury,85 86 there seems to be 
little doubt that DWI is better at detecting axonal shearing. In one study, DWI identified 
30% more shearing injuries than conventional MRI within 48 hours of head injury, with 
most of these seen as an increase in ADC.84
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Figure 12. DTI images from one of our patients imaged acutely and at one year after head 
injury. Diffusion weighted images (left), and DTI, FA map (right), obtained within 24 hours 
of head injury’ demonstrate the value of DTI imaging in demonstrating axonal injury. The 
loss of white matter anisotropy in the right frontal region is evident on the FA map, and 
coincides with a hvperintense lesion on the DWI frame. Follow up DTI at one year (lower 
image pair) show that the white matter tracts have, in the main, survived intact
MRI in acute head injury -  perfusion weighted imaging
While some experimental studies have reported on the use of PWI, there are no
published clinical studies using the technique in head injury (although BOLD fMRI
techniques have been used for functional imaging in the follow up of patients after head
injury).87
3.2.9 Interpretation of findings
The data presented in this chapter show the prominent and growing role of diffusion and 
perfusion MR in defining, diagnosing and understanding traumatic brain injury. 
However, while several experimental and clinical studies have revealed intriguing 
findings, their interpretation is not straightforward. Our understanding of the 
pathophysiology underlying acute CNS insults is based on a conceptual framework 
generated in the setting of stroke. While several questions remain to be answered in the 
setting of stroke, the large clinical database and a substantial experimental literature 
have allowed us to at least define the boundaries of our understanding and provide an 
integrated (if incomplete) picture of how clinical DWI and PWI changes may be 
interpreted.
40
Review of the Literature
Unfortunately, it is unlikely that these principles can be directly translated to traumatic 
brain injury, where pathophysiology is more complex, and the sequence of processes 
that affect brain water content and distribution may be different. For example, the 
widespread perfusion abnormalities in early head injury7 may make it inappropriate to 
use contralateral brain as a “normal” control, even when this seems structurally normal. 
This makes the interpretation of relative CBF images much more complex. Similarly, 
the coexistence of low cerebral blood volume and cerebral blood flow in many patients 
suggests abnormal microvascular physiology, while the presence of vascular 
engorgement in the subacute phase can substantially increase cerebral blood volume and 
confound the application of algorithms that derive absolute or relative CBF maps. 
Finally, the experimental data suggest that ADC reductions in head injury are not always 
accompanied by reductions in CBF to levels that are typical o f ischaemic cytotoxic 
oedema, and that other mechanisms may be responsible for these imaging findings.
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3.3 Management of Head Injury
The emphasis of current head injury management guidelines is focused on the 
prevention of secondary injury.88 89 These guidelines aim to optimise cerebral perfusion 
and the control of intracranial pressure.
INTRACRANIAL PRESSURE AND HYPERVENTILATION 
Intracranial hypertension is traditionally defined as an ICP greater than 20 mmHg. 
Increased ICP will reduce CPP, unless MAP rises in parallel, and if  severe, carries the 
risk of cerebral herniation. Above an ICP of 20 mmHg the compliance of the intracranial 
space rapidly decreases, such that small increases in intracranial volume produce large 
increases is intracranial pressure.
While ICP monitoring has never been subjected to a prospective randomized clinical 
trial to establish its efficacy in improving outcome from severe head injury, it provides a 
major target for most modem therapies in head injury management and is recommended 
in expert guidelines.90 Improvements in outcome following traumatic brain injury (TBI) 
have been associated with management protocols incorporating ICP monitoring9192 and 
support a strong relationship between increased mortality and morbidity and raised ICP 
or poor ICP control.93 94 In particular, data from the Traumatic Coma Data Bank suggest 
that an ICP greater than 20 mmHg is strongly predictive of a poor outcome following 
head injury.94
General measures for ICP control include control of body temperature, seizure 
prophylaxis, elevation of the head of the bed, avoidance of jugular venous outflow 
obstruction, sedation and muscular paralysis, maintenance of adequate arterial 
oxygenation, cerebrospinal fluid drainage, and fluid resuscitation and vasopressor 
support to maintain a CPP > 70 mmHg.95 During the period of research expert guidelines 
were revised and recommended a lower CPP target of 60 mmHg,96 however the hospital 
protocol for CPP management did not change to reflect this until after these experiments 
were complete. When intracranial hypotension was refractory to conventional therapy, 
‘second tier’ therapies including hypertensive therapy to increase CPP and 
hyperventilation should be considered. Hyperventilation, via a reduction in PaCC>2, 
results in cerebral vasoconstriction and a reduction in CBV; a reduction of PaCCb of 1 
kPa producing around a 20% reduction in CBV (figure 13).97
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Figure 13. The effect of PaC02 on CBF and CBV. CBF and CBV change linearly with 
PaC02 within the physiological range. This C02 reactivity is affected by the duration of 
hyperventilation, injury and the effect of drugs; however, as an approximation, CBF falls 
by 10-15 ml/lOOg/min for every 1 kPa fall in PaC02.
Consequently, hyperventilation has been extensively used in the past for the control of 
intracranial hypertension in patients with TBI.98-100 However, hyperventilation produces 
reductions in CBF (Fig 9).97101 Increasing evidence suggests the presence of early 
cerebral hypoperfusion (and possibly ischaemia) in patients with TBI,461 102 and there are 
concerns that hyperventilation induced reductions in CBF may precipitate or worsen 
ischaemia98 101 103 and affect outcome.104 Such concerns have led to recommendations 
regarding the use of hyperventilation therapy in head injury.105 These advocate the 
avoidance of hyperventilation within the first 24 hours of injury, when blood flow is 
commonly reduced.4 However, they still include hypoventilation as a therapeutic option 
in those patients with intractable intracranial pressure during the later phases of injury.
Recent lsO-PET imaging studies demonstrating no acute fall in CM R02 with 
hyperventilation,106 107 contrast with others studies suggesting that hyperventilation 
produces acute ischaemia, seen as an increase in oxygen extraction.101 Bedside 
measurement of the adequacy of CBF would allow rational use of hyperventilation. 
However, available methods, such as jugular bulb oximetry and TCD, are unable to 
reliably distinguish whether such interventions result in or worsen regional ischaemia. 
While hyperventilation is known to reduce cerebral perfusion, it may not result in true 
ischaemia.106 107 Consequently, PaC02 levels as low as 4.0 kPa are commonly employed 
to treat intracranial hypertension, and this practice falls within accepted guidelines.98 
However, the safety of such therapy remains unproven.
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CEREBRAL PERFUSION PRESSURE 
Following head injury, cerebral autoregulation is frequently impaired (figure 14) 
addition, the autoregulatory curve may be shifted to the right.110
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Figure 14. Autoregulation. The curves illustrating partial or complete autoregulatory 
impairment The arrows show how inflection points of the curve move as autoregulation 
changes.
If autoregulatory mechanisms within the injured brain are impaired, then moderate 
reductions in CPP will reduce CBF and may lead to ischemic injury. Indeed, intact 
autoregulation is associated with improved outcome in head injury.10811(M 12
Evidence of early cerebral hypoperfusion (and possibly ischaemia) in patients with 
TBI,61102 have lead some institutions to implement CPP oriented management,113 
however there is little consensus on the target level of CPP, with suggested thresholds 
ranging from 50 to 85 mmHg.113114 To achieve a sustainable increase in CPP, aggressive 
fluid resuscitation and hypertensive therapy such as systemic vasopressors are usually 
required. These treatments carry risks, including cardiac and respiratory complications.93 
Indeed, the while guidelines for the management of severe head injury published by the 
Brain Trauma Foundation in 2000115 state that a CPP above 70 mmHg is a treatment 
option, a more recent update from the BTF suggests that CPP should be maintained 
above 60 mm Hg, and attempts to elevate CPP above 70 mmHg with aggressive volume 
supplementation and vasopressor therapy should be avoided.96 An alternative 
management approach based on reducing cerebral oedema has been suggested by the 
Lund group in Sweden,116 and accepts a lower minimum CPP. This approach is based on 
the premise that high CPP results in vasogenic oedema and intracranial hypertension. 
Treatment is based on the use of low dose barbiturate, metoprolol, clonidine and
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dihydroergotamine. Outcome data using this approach are comparable to those from 
trials of CPP directed head injury management.114 The ‘Lund protocol’ has not been 
universally accepted as a management strategy and its position requires confirmation by 
further controlled studies, and direct comparison with conventional therapy.
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Methods
4.1 Clinical Protocols
All patients admitted to the neurosciences critical care unit (NCCU), Addenbrooke’s 
Hospital, Cambridge following head injury which was significant enough to require 
mechanical ventilation either for airway protection because of a decreased level of 
consciousness (GCS<9) or for the control of raised intracranial pressure were eligible for 
recruitment.
All studies were approved by the Local Research Ethics Committee at Addenbrooke’s 
Hospital, Cambridge, UK. and by the Administration of Radioactive Substances 
Advisory Committee of the UK.
Patients were managed with protocol driven therapy aimed at maintaining ICP below 20 
mmHg and CPP greater than 70 mmHg, as previously described,117 and detailed in the 
NCCU management protocol (Figure 15). Interventions included sedation (propofol up 
to 8 mg/kg/hr and fentanyl 1 - 2  /xg/kg/hr) and neuromuscular blockade, surgery for 
space-occupying lesions, drainage of cerebrospinal fluid (CSF), volume supplementation 
and vasoactive agents (dopamine and/or norepinephrine) for CPP augmentation, 
osmotherapy (mannitol and hypertonic saline), and mild hyperventilation (to ~4.5 kPa). 
Hyperthermia was treated vigorously, and mild hypothermia (~36 °C) was commonly 
employed to assist ICP control.
In patients, a fibreoptic right jugular bulb catheter (Baxter, Newbury, UK) was inserted 
and its position confirmed radiologically. Samples of arterial and jugular venous blood 
were drawn for simultaneous measurement of arterial blood gases and SjC>2 and 
calculation of AJDO2 .
During imaging studies intensive care therapy and haemodynamic targets were 
maintained by titrating fluids and vasoactive agents, sedative infusions were left 
unchanged.
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All patients with or at risk of intracranial hypertension must have invasive arterial 
monitoring, CVP line, ICP monitor and Rt SJ02 catheter at admission to NCCU.
Aim to establish TCD and multimodality computer within the first six hours of NCCU stay.
Interventions in stage II to be targeted to clinical picture and multimodality monitoring.
Check whether the patient is in or may be a candidate for research protocols.
Guidelines may be modified at the discretion of the consultant in charge.
Treatment grades III and IV only after approval by NCCU Consultant.
m
no
no
No
yes
yes
CT
Yes
Surgery
ICP < 20 
CPP > 70
- recent CT
- low risk of 
surgical lesion
CPP < 70; ICP > 25 (Check probe, ? re-CT)
CPP < 70; ICP > 25 (Check probe, ? re-CT)
Surgical lesion? 
CSF drainage ? 
Role for surgical 
decompression?
Temp 33 °C (discontinue propofol)
Trial of bolus Lv. anaesthetic (e.g. Propofol 50-200 mg),
- maintain CPP with fluids and vasoactive agents
If favorable effect on ICP and CPP start thiopentone
- 250 mg boluses up to 3-5 g + infusion 4-8 mg/kg/hr to 
achieve and maintain burst suppression
>20% mannitol 2ml/kg X 3 or till plasma 320 mosm/1 
■PAC, volume, vasoactives to increase MAP (CPP 90-100) 
■Reduce PaCO 2 to ~ 4.0 kPa providing SJO 2 stays > 55%, 
>Temp ~ 35°C, Daily lipid screen if still on propofol 
>EEG: ? fits -> Institute or escalate antiepileptic therapy 
’Consider 5% NaCI 2ml/kg (can repeat if Na < 150 mmol/1) 
•Consider THAM if chronically hypocapnic (see protocol)
■10-15° head up, no venous obstruction 
CPP > 70 (CVP 6 - 10; + PAC)
Sp02 > 97% ;Pa02 > 11 kPa, PaC 02 43-5.0 kPa 
■Temp < 37°C; SJ02 > 55%; blood sugar 4-7 mmol/1 
■Propofol 3-5 mg/kg/hr (midazolam ~ 0.1 mg/kg/hr from day 2) 
Fentanyl 1-2 pg/kg/hr; atracurium 0.5 mg/kg/hr 
■Sucralfate lg  og 6 hrly (Ranitidine 50mg 8 hrly iv if no OGT 
or aspirate >200ml/6 hrs)
Phenytoin 15 mg/kg if indicated (fits, depressed # etc)
Figure 15. Addenbrooke’s NCCU ICP/CPP management algorithm. NCCU: Neurosciences 
Critical Care Unit; CVP: central venous pressure; ICP: intracranial pressure; Rt: right; 
SJ02: jugular bulb oxygen saturation; TCD: transcranial Doppler; CPP: cerebral 
perfusion pressure; PAC: pulmonary artery catheter; Pa02: arterial partial pressure of 0 2; 
PaC02: arterial partial pressure of C 02; OGT: oral gastric tube; MAP: mean arterial 
pressure; CSF: cerebrospinal fluid; Rx: therapy; Sp02 peripheral oxygen saturation; CT: 
computed tomography; Temp: temperature; EEG: electroencephalogram; THAM: Tris- 
Hydroxy-Methyl-Amino-Methane.
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4.2 Three Tesla MRI Sequence Details
This section outlines the Wolfson Brain Imaging Centre (WBIC) clinical DTI sequence 
used for the DTI studies in this thesis and the structural images which were used for 
comparison and coregistration.
Three Tesla MRI All scans were performed at the WBIC on a Bruker Medspec 3 Tesla 
actively shielded MRI scanner (Bruker Biospin MRI, Germany). It should be noted that 
3 Tesla MRI scanners are not currently in widespread use; however the higher field 
strength has several advantages (including importantly improved DTI resolution).
4.2.1 DTI
The DTI sequence uses an EPI acquisition to reduce scanning time and minimise motion 
artifact. The strength of the gradients was modulated from 0 to 30mT/m to generate the 
5 b-values of 318, 637, 955, 1274, 1541 s/mm2. These b-values take into account that the 
gradient profile deviates from a delta shape due to the finite rise time of the diffusion 
gradients. The gradients were applied at all five b-values in each of the 12 directions, 
calculated using an electrostatic repulsion algorithm designed to maximise the 
separation of the individual gradients. The imaging parameters were as follows 
Matrix size: 100 x 100 [reconstructed to 128x128]
Field of view: 190 x 190mm 
In-plane pixel dimension: 1.9 x 1.9mm 
Slice thickness: 5mm 
Echo time (TE): 100ms 
Repetition time (TR): 6000ms.
4.2.2 Fluid Attenuation Inversion Recovery (FLAIR) Sequence
The imaging parameters were as follows:
Matrix size: 256x512 
Field of View: 168 x 358mm 
Inversion Time (TI): 2213ms 
Echo time (TE): 20ms 
Effective echo time (ETE): 135ms 
Recovery time (TR): 111 90ms
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4.2J Gradient Echo (GRE) Sequence
The GRE sequence uses paired gradients rather than spin-echo to refocus the T2 MRI 
signal. However T2* effects, such as those from blood, are not refocused by the 
gradients. Therefore tissue which contains blood appears very dark on GRE images. 
While in some respects this is a limitation of GRE sequences, if signal loss is seen 
around a contusion it implies the presence of blood. It is also therefore a useful 
technique for detecting small-haemorrhages associated with diffuse axonal injury. The 
imaging parameters were as follows:
Matrix size: 256x256 
Field of view: 165 x 220mm 
Recovery time (TR): 2009ms 
Echo time (TE): 30ms 
Flip angle: 90 degrees
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4.3 PET Imaging Protocols and Image Analysis
All studies were undertaken using a General Electric Advance scanner (GE Medical 
Systems, Milwaulkee, USA). The standard data acquisition sequence used at the WBIC 
was as follows: A transmission scan for attenuation correction was performed in each 
patient. This was followed by a 90 second inhalation o f 750 MBq o f ClsO and a single 
five minute frame was acquired. For calculation of CBV, blood samples were taken from 
an arterial line at 60 and 360 seconds. This was followed by a 20 minute inhalation of 
7200 MBq of ,5(>2 . Two five minute emission frames were acquired during the last ten 
minutes o f this steady state inhalation and the two frames averaged. For calculation of 
oxygen metabolism arterial blood samples were taken at 10, 15, and 20 minutes. Finally 
a 20 minute infusion of 800MBq of H2150  was delivered intravenously. Two five minute 
frames of emission data were acquired in the last ten minutes of the infusion and the 
frames averaged. Arterial blood samples were taken at 10, 15 and 20 minutes to allow 
calculation o f CBF.
Images were reconstructed using the PROMIS 3D filtered back projection algorithm118 
with corrections applied for attenuation, scatter, dead time and randoms. Maps of 
regional CBF, CBV, CMR02 and OEF were constructed using the emission data and the 
arterial tracer activity, as discussed in section 2.2. The maps were constructed using “in- 
house” PETAN software (written by Dr P. Smielewski).
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4.4 Image Processing
4.4.1 Coregistration
Simply put, coregistration is the process of making the structures in a pair of images 
match up. However the details of this process are conceptually and mathematically 
complex. My research did not contain any development of these techniques. However 
since coregistration was used as a tool in image analysis, the principles involved will be 
briefly outlined.
An example of coregistration would be to take a pair of images from the same patient, 
for instance two MRI scans taken on different days, and align one of the image pairs so 
that the brain and other structures on the two images line up. The pairs of images may 
come from the same imaging modality or from two different imaging modalities, for 
instance MRI and PET. Coregistration can be used to correct for patient movement or 
differences in image scaling. Mathematically coregistration tries to transform voxels in 
the two images in order to minimise a numerical measure of mis-match (this is termed a 
cost function). The voxels in one of the images are then transformed such that the image 
rotates, changes size, stretches or tilts (or a combination of these) so that the images are 
a similar size and the brain structures match up. For coregistration between similar 
image types the image transformation is a matter of scaling, rotating, shearing, and 
tilting one o f the images until the pairs match; this type of coregistration is called an 
affine transformation, an example is shown in figure 16.
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(coreg istered )
Initial S ca n  
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Figure 16. Affine coregistration. Top image pair showing initial and follow up MRI scans 
from a patient, these images are not aligned. The bottom image pair are the same images 
except the follow up scan is has now undergone a rigid body coregistration and the images 
are now aligned.
A more complex type of coregistration is termed a non-linear transformation, it is used 
when there are marked distortions in one of the images. Here the coregistration allows 
individual voxels to be moved or scaled so that different regions may undergo 
independent transformation. This may allow distorted regions in the image to be pulled 
back towards the reference image. An example is shown in Figure 17.
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Figure 17. Top image pair show FLAIR and ADC image which are unaligned, the ADC 
image has different contrast and has distortions particularly in the frontal and occipital 
regions (arrowheads). These distortions make the brain appear elongated in the antero­
posterior direction. The distortions are common in EPI sequences and are due to field 
inhomogeneities caused by the air tissue interface around the air sinuses. The lower image 
pair shows the effect of a non-rigid coregistration on the ADC Image. The images are 
aligned and the distortions greatly reduced.
If the image pairs have different tissue contrast but reflect the same underlying 
structures, a cost function such as mutual information or normalised mutual information 
(NMI) can be used. These cost functions minimise the error in the amount of 
information about underlying structure which the images share even though the contrast 
may differ. As an everyday example of this it would be fairly easy to pair up a 
photographic negative and the photo itself because the images share structural 
information even though they have quite different contrast.
After transformation of the image the values of the voxels require recalculation. This 
process is termed interpolation, and there are different algorithms which can be used for 
this purpose. Three commonly used interpolation algorithms are nearest neighbour, 
trilinear and sine.
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Nearest neighbour interpolation
This applies the value from the voxel in the original image which is nearest to the new 
voxel in the new image. It is the simplest method as does not alter the original values 
and does not smooth the image in any way, but it may result in a voxel value being 
duplicated if the image is enlarged during transformation.
Trilinear interpolation
This applies a weighted average value to the new voxel based on the value of the 
surrounding voxels in the original image. Trilinear refers to the three dimensions (x, y 
and z) over which the interpolation must obtain the weighted average. This type of 
interpolation changes the values of the voxels and smoothes the image somewhat.
Sine interpolation
Like trilinear interpolation, this method this gives a value to the new voxel based on the 
surrounding voxels, but uses a sine function to weight the various surrounding values 
rather than the linear weighted average. Sine interpolation is computationally much 
slower than trilinear interpolation but theoretically may better relate to the underlying 
physics of the imaging techniques.
4.4.2 Implementation of Coregistration in Practice
For comparison between images of different types images were coregistered to the same 
space using the FLAIR image as a the reference image (the image to which other images 
were registered) with NMI as a cost function and trilinear interpolation. Since 
coregistration works best with images which have a high signal to noise ratio (SNR) 
DWI images (such as the b=0 DWI) were used for coregisteration and the transformation 
file created in the coregistration was then applied to coregister other images from the 
same data with lower SNR (such as the ADC map). An example of the contrasting SNR 
in images from the same acquisition are shown (Figure 18). Similarly for coregistration 
between PET and FLAIR the (high SNR) CBF map was coregistered and the same 
transformation applied to the (low SNR) CBV, OEF and CMRO2 PET maps. For 
comparison between images of the same type (e.g. the test-retest and pre- and post­
hyperventilation ADC images) the image pairs were coregistered to each other using an 
affine, rigid body transformation using NMI and nearest neighbour interpolation (to 
avoid smoothing).
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Figure 18. Image signal to noise ratio. The b=0 DWI image has the same structure as the 
ADC map but the high SNR makes it preferable for coregistration.
While automated image coregistration is an objective method of coregistration between 
pairs of images whether the registration is “good enough” remains a subjective judgment 
and therefore difficult to quantify. For comparison of image pairs of different types 
which were not distorted (e.g. PET to FLAIR) an affine, rigid body coregistration 
produced the best results. For comparison between images with distortions due to echo- 
planar acquisition (e.g. ADC images to FLAIR) it was generally necessary to use a non- 
rigid coregistration to achieve acceptable results, however there were some ADC images 
where a rigid coregistration produced a superior result to a non-rigid coregistration and 
in these cases the rigid coregistration was used. In all cases the decision regarding the 
type of coregistration used was not influenced by the results of subsequent image 
analysis.
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4.5 Statistical Methods
Some aspects of the statistical methods used are specific to individual chapters, and are 
discussed in those chapters separately. This section deals with the general principles of 
the statistical analysis used.
Statistical analysis was performed using SPSS 11.5 (SPSS Inc., Chicago, Illinois, USA). 
Non-parametric data comparisons were performed using a Mann-Whitney U test and 
parametric comparisons were performed using an impaired t-test or one way ANOVA 
with Bonferroni correction of multiple comparisons where appropriate. Linear 
correlations between non-parametric data were performed using the Spearman 
correlation coefficient.
P-values of less than 0.05 were considered significant. In the test-retest data confidence 
intervals of 99% were used to minimise the chance o f a type 1 statistical error.
The statistical tests used in the individual studies are described in more detail in the 
respective sections.
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5.1 Infusion Pump Testing at 3 Tesla
5.1.1 Introduction
Critically ill patients who are undergoing MRI often require the delivery of intravenous 
infusions by infusion pump, however there are concerns about the safety of such 
equipment in a magnetic resonance (MR) environment119120 Many pumps are partly or 
substantially constructed of ferromagnetic components and represent a projectile risk in 
the high strength magnetic field used for MRI, in addition some components of these 
devices such as the electric motor, strain gauges, micro-switches and electronic sensors 
could have their performance affected by the strong static magnetic field, switching 
magnetic gradient fields or radio frequency (RF) fields. The term M R safe’ indicates 
that a device used in the MR suite it does not present any additional risk to the patient 
and the term M R  compatible’ indicates that a device will not affect the diagnostic 
quality of the imaging procedure, or have its operations affected by the MR scanning 
system. Such terms apply up to the limits at which the equipment was tested.1-1 123 While 
the MR compatibility of a previous generation of infusion pumps had been 
documented,124 it became likely that, over the course of these studies, these would be 
replaced by a newer generation of pumps. These studies were therefore undertaken to 
ensure that the new pumps could be used during MR studies on critically ill patients.
5.1.2 Methods
The performance of two infusion pumps, the Alaris P6000 (Part number: 
6001FA3UUN2) and Alaris Asena-GH (Part number: 80023GB00) (ALARIS Medical 
UK Ltd.) as shown in Figure 19, were tested within the MR environment of the 
Wolfson Brain Imaging Centre, as part of our research programme. These pumps were 
chosen because they are the main pumps used on NCCU and since they are primarily 
constructed of foam filled plastic casing and most major mechanical components are 
constructed from non-magnetic aluminium alloy we believed they would present a low 
projectile risk.
Figure 19. Alaris infusion pumps P6000 (left) and Asena-GH (right)
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All studies were performed in an MR imaging system comprising a Bruker Medspec 3 
Tesla actively shielded scanner (Bruker Biospin MRI, Germany). Pump flow rate was 
tested using a gravimetric system, as shown in Figure 20, that has been previously 
described124 and a BD 50ml disposable syringe (Becton Dickinson, NJ, USA).
The gravimetric system calculates the mean flow rate from the mass of water, of known 
density, collected over time. To reduce the error at the start of each measurement, while 
driving pressure developed in the syringe and flow rate stabilised, the pumps were 
operated for between five and ten minutes before the start of each gravimetric 
measurement. Evaporative loss from the collecting flask was reduced by a rubber bung, 
placed in the neck of the flask, containing an inlet tube and a narrow air vent. Pump flow 
rate function was tested at two static field strengths, five Gauss (the limit of fringe field) 
and 100 Gauss (well within the usual site of our pumps for imaging). All static magnetic 
field strengths were obtained from the Gauss lines map and in order to control for 
possible effects of magnetic field orientation all flow rate experiments were conducted 
with the infusion pump aligned both parallel and transverse to the direction of the main 
static magnetic field. Each flow rate measurement was conducted once at each field 
strength and orientation, the mass of water was recorded every 30 seconds and the mean 
flow and mean error were calculated. The tests were conducted at static field strengths of 
five Gauss with an infusion rate of lOml/h (over one hour) and at 100 Gauss with 
infusion rates of lml/h (over one hour), 10 ml/hr (over one hour) and lOOml/h (over 30 
minutes). In order to assess the effects of gradient and RF fields on pump performance, 
the accuracy of the device was tested at 100 Gauss with an infusion rate of lOml/h (over 
one hour) whilst a T2 sequence using large RF frequency field pulses was run (spin-echo 
sequence parameters: TE - 80ms, TR - 6056ms). In order to assess the effects of long­
term exposure to magnetic fields the pumps were tested at the 100 Gauss with an 
infusion rate of lOml/h whilst the sequence described above was operated continuously 
for five hours. In all flow rate experiments a mean error of less than five percent was 
considered acceptable and this is in line with our hospital policy. Occlusion pressure 
limit alarm function was measured using a digital pressure gauge (DPI 705, Druck pic, 
UK). The infusion pumps have an adjustable occlusion pressure alarm, graduated from 
LI to L8, and this was tested at three pressure limit levels L2 (low), L4 (medium) and 
L6 (high). The pressure at these levels was measured outside the field and then at two 
field strengths (50 and 100 Gauss), each measurement was repeated ten times to obtain a 
mean occlusion pressure. The gravimetric balance system and pressure gauge were sited 
outside the scanning room, beyond the five Gauss line. All other remaining sensors were 
tested at the highest field strength (100 Gauss). To assess the effect of the pumps on
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image acquisition a MR phantom was imaged using a proton density/T2 weighted dual­
echo sequence (sequence parameters: matrix size - 512 x 256mm, field of view - 36 x 
17mm, slices - 27, TE - 20 & 80ms, TR - 6056ms). Images were obtained under three 
conditions, baseline with no pump present and then with the each pump operating whilst 
positioned by the side of the imaging couch at a static field of 100 Gauss. The images 
obtained with the pumps present were inspected for evidence of artifact and compared to 
the baseline image. The gravimetric and pressure occlusion tests were repeated away 
from the scanner at the end of these experiments. Finally the projectile risk was assessed 
by suspending the pumps from a rope at the entrance to the bore of the scanner. The 
horizontal force due to the magnetic field was calculated from the angle of deflection of 
the pumps.
c o c o
Figure 20. Diagram of the gravimetric system used to evaluate pump flow rate. Showing: A 
- infusion pump within the MR scanning room, B - manometer line, C - wave guide passing 
through the w all of the scanning room, acting as conduit for the manometer line, D - 
receiving flask and scientific balance, outside the scanning room and beyond the five Gauss 
line and E -personal computer recording the output of the balance.
Statistical Analysis
All statistical calculations were carried out using StatView 5.0 statistical software (SAS 
Institute Inc., Cary, NC, USA). A mean flow rate error of less than five percent was 
considered acceptable and this is in line with our hospitals policy for pump testing. 
Continuous parametric data (pressure alarm limits) were compared with paired two 
tailed t-tests. A p-value of less than 0.05 was considered to represent a significant 
difference.
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5 .U  Results
FLOW RATE
Table 5.1 and table 5.2 summarise the results of the gravimetric flow rate tests. Both 
infusion pumps were found to perform within acceptable limits for the gravimetric flow 
rate tests. The maximum mean error recorded for the Alaris P6000 was 2.18% of the set 
flow and for the Asena-GH was 1.42%, both well within our set limits. The variation in 
instantaneous error during the pump testing at 100 Gauss and 5 Gauss was no greater 
than the variation away from the scanner. The alignment o f the pump relative to the 
main magnetic field did not affect flow rate performance at any field strength. The 
presence of switching gradient and RF fields used during the imaging sequence did not 
produce any additional effect on pump flow rate performance.
OCCLUSION PRESSURE LIMITS
Table 5.3 summarises the results of the occlusion pressure alarm tests. The P6000 pump 
showed a significant difference in occlusion pressure alarm at all three pressure settings 
at both 50 Gauss and 100 Gauss. At 50 Gauss, compared to performance outside the 
field, the alarm sounded at mean pressures 182, 62 and 20 mmHg higher, for low, 
medium and high pressure settings respectively (all p-values < 0.001). At 100 Gauss, 
compared to performance outside the field, the alarm sounded at a mean pressure o f 204 
and 98 mmHg higher and 24 mmHg lower, for low, medium and high pressure settings 
respectively (all p-values < 0.001). For the Asena-GH pump at 50 Gauss, compared to 
performance outside the field, the alarm sounded at a mean of 61, 12 and 8 mmHg 
lower, for low, medium and high pressure settings respectively (p-values <0.001,0.002 
and 0.058). At 100 Gauss, compared to performance outside the field, the alarm sounded 
at a mean pressure of 99, 4 and 2 mmHg lower, for low, medium and high pressure 
settings respectively (p-values <0.001, 0.088 and 0.619).
OTHER EFFECTS
All other safety mechanisms worked as expected up to 100 Gauss on both pumps, 
including the audible alarm. The sensor mechanisms fitted to the pumps were tested by 
enforcing an error to occur (e.g. end of travel) and did not appear susceptible to 
magnetic interference. The pumps were not found to cause any appreciable artifact on 
the proton density/T2 weighted images and no other effect on scan quality was found. 
Pump performance was unchanged in tests conducted after magnetic field exposure. 
There was no deflection of the pumps at 100 Gauss field strength. However, when 
suspended at the entrance to the scanner (in excess of 500 Gauss static field and one
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Tesla per metre field gradient) the P6000 pump (weight 3.275kg) was deflected from 
vertical by 65 degrees; the horizontal force was therefore 72. IN and the Asena-GH 
(weight 2.466kg) was deflected by 59 degrees; the horizontal force was therefore 37.7N.
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Alaris P6000
Rate
(direction to field)
1 ml per hour 
(parallel)
1 ml per hour 
(transverse) 
10ml per hour 
(parallel)
10ml per hour 
(transverse) 
100ml per hour 
(parallel)
100ml per hour 
(transverse) 
10ml per hour 
T2 sequence
Beyond 5 Gauss 5 Gauss
Mean
Flow
Mean 
Error %
Mean
Flow
100 Gauss
Mean 
Error %
Mean
Flow
Mean 
Error %
100.57
Table 5.1. The results of the flow rate tests for the Alaris P6000 pump at different infusion 
rates, directions and static field strengths. The last row shows the results for the pump 
whilst a T2 weighted sequence was running for five hours to assess the effect of RF 
interference.
64
Methodological Developments
Alaris Asena-GH
Beyond 5 Gauss 5 Gauss 100 Gauss
Rate
(direction to field)
lml per hour 
(parallel)
lml per hour 
(transverse)
10ml per hour 
(parallel)
10ml per hour 
(transverse)
100ml per hour 
(parallel)
100ml per hour 
(transverse) 
10ml per hour 
T2 sequence
Mean
Flow
Mean 
Error %
Mean
Flow
Mean 
Error %
Mean
Flow
0.98
0.99
9.99 -0.03 9.93
10
- 0.68
0.05
10.11
10.14
Mean 
Error %
-1.7
-1.3
1.07
1.42
Table 5.2. The results of the flow rate tests for the Alaris Asena-GH pump at different 
infusion rates, directions and static field strengths. The last row shows the results for the 
pump whilst a T2 weighted sequence w as running for five hours to assess the effect of RF 
field interference.
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P6000 Asena-GH
Mean Difference p-Value Mean Difference p-Value
Low pressure limit 
(0-50 Gauss)
-182 mmHg <0.001* 61 mmHg <0.001*
Medium pressure limit 
(0-50 Gauss)
-62 mmHg <0.001* 12 mmHg 0.002*
High pressure limit 
(0-50 Gauss)
-20 mmHg <0.001* 8 mmHg 0.058
Low pressure limit 
(0-100 Gauss)
-204 mmHg <0.001* 99 mmHg <0.001*
Medium pressure limit 
(0-100 Gauss)
-98 mmHg <0.001* 4 mmHg 0.088
High pressure limit 
(0-100 Gauss)
24 mmHg <0.001* 2 mmHg 0.619
Table 53. The mean difference in the occlusion pressure limit, between 0 and 50 Gauss and 
between 0 and 100 Gauss for each pump. The p-values are shown. Significant differences 
are highlighted with an asterisk.
5.1.4 Conclusion
We have shown that the mean infusion rates and mean errors of the Alaris P6000 and 
Alaris Asena-GH pumps are unchanged in an MR environment up to 100 Gauss. Neither 
pump was affected by the RF or gradient fields used in imaging and neither pump 
affected image quality. The effect of the MR environment upon the occlusion pressure 
alarm of the P6000 pump may have safety implications since, if the set pressure limit is 
exceeded, a larger bolus volume could be delivered when the occlusion is released. 
Whilst the MR environment affected the pressure limit alarm of the Asena-GH, the 
occlusion pressure differences were small and their main consequence would be the 
alarm sounding prematurely. This is unlikely to have patient safety implications. Both 
pumps were deflected by the magnetic field at the entrance to the scanner and were 
subjected to a significant attractive force, which was greater than the force exerted on 
the device by gravity. However, this attractive force was only manifest close to the 
opening of the magnet, at a static field of over 500 Gauss and a field gradient exceeding 
one Tesla per metre. We have shown that the Asena-GH can function accurately and 
safely provided the pump is kept no closer than 100 Gauss and secured to an immovable 
object. However neither pump can strictly be classified as either MR safe or MR
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compatible; the pumps are only likely to be able to fulfil such definitions if 
ferromagnetic components were reduced so that the overall translational force on the 
device became negligible. If such modifications are made, or the pump is used with the 
caveats outlined above, pump function may be affected by prolonged exposure to strong 
magnetic fields, and careful testing of any pump used within a MRI setting must take 
place regularly to ensure continued reliability.
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5.2 Determination of the Test-Retest Reproducibility of 
DWI
5.2.1 Introduction
If ADC maps are obtained twice in an individual patient the ADC values obtained will 
often differ. This variability of ADC measurement is termed the test-retest variability. 
The reasons for non identical results are partly real changes in diffusion between the two 
scans, but also results from to noise in the scanning system. The limits of the test-retest 
reproducibility need to be defined to make judgements about the significance of ADC 
changes in patients. It is also needed to determine the significance of any ADC change 
in a group of patients undergoing a therapeutic intervention. The test-retest 
reproducibility of ADC values in head injured patients is as yet unreported.
5.2.2 Patients and Methods
The test-retest reproducibility was determined in a group of six head injured patients.
The patients underwent two identical DTI sequences, separated by an average interval of 
28 minutes, with every effort made to maintain stable physiology across the two scans.
In particular, the mean change in PaCC>2 was 0.07kPa, and in no patient did the PaC02 
change by more than 0.2 kPa. The mean change in CPP was 0 mmHg, and in no patient 
did the ICP or CPP change by more than ±3 mmHg. Patient characteristics are given in 
Table 5.4.
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No. Age
(yrs)
Sex Mechanism 
ofInjury
Hrs.
from
Injury
GCS Marshall
Score
Apachell
Score
ISS Interval
(min)
1 52 F RTA 8 4 EML 24 49 17
2 41 F RTA 27 5 DI2 19 21 51
3 19 M RTA 54 8 EML 19 25 25
4 30 M RTA 62 6 DI3 19 30 19
5 41 M Fall 71 6 DI3 16 43 15
6 36 M RTA 71 8 EML 15 16 39
Table 5.4. Patient characteristics for the test-retest reproducibility of ADC study. Marshall 
score125 EML: evacuated mass lesion. The last column ‘Interval’ refers to the time (in 
minutes) between the first and second
DTI sequences and image analysis
The ADC maps were calculated, coregistered to one another and non-brain structures 
were excluded, The brain was manually outlined and the edge eroded by two pixels to 
reduce edge artifact and to ensure that the analysis was restricted to brain voxels.
Since the ADC maps are generally similar the small changes in ADC between the two 
can best be perceived and quantified by subtracting one map from the other. This map of 
the changes in ADC between the two scans was termed the delta ADC (AADC) map.
The AADC map was created by subtracting the first ADC map from the second ADC 
map (figure 21). The AADC map, therefore, has negative values in areas where diffusion 
has decreased on the second scan and positive values in areas where diffusion has 
increased on the second scan.
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Figure 21. The calculation of AADC maps. The two ADC maps are coregistered and brain 
structures are excluded the first ADC map is subtracted from the second to create the 
AADC map.
69
Methodological Developments
* .  a x
: 190 o o t i i c  oc o a a u
2 ’27. 190 odtlJO.OO OOOO (138.UI
t  .  a  xi27[ mooiHoogoaoaia.ia i:
jii&iii ft si
T  .  n X
60»1<
The changes in ADC can also be standardised as a fractional change in ADC. This 
fractional change in ADC, relative to the ADC values in the first scan, was calculated by 
dividing the AADC map by the first ADC map to create the fractional AADC (fAADC) 
map (figure 22).
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Figure 22. The calculation of fAADC maps. The AADC map is divided by the ADC map 
from the first scan to create the fAADC map.
AADC may vary between tissue types within the brain and therefore regions of interest 
were developed which allow the analysis of AADC within specific tissue types.
Seven regions of interest were developed using the first ADC map and FA maps. In all 
regions non-brain structures were excluded from the image analysis. The regions were:
Region 1. The whole volume (i.e. all slices).
Region 2. The two or three slices which showed the contusions most clearly.
Region 3. The pericontusional region including the core, oedema and an area of tissue 
approximately 3-4mm thick around the contusion. An examples is shown in 
figure 23
Region 4. The hyperintense region around the core of the contusion which represents 
vasogenic oedema. An examples is shown in figure 23 
Region 5. The thin hypointense rim of tissue outside the vasogenic oedema, this region, 
its possible composition and origin are discussed further in chapter 5. An 
example is shown in figure 23.
Region 6. The normal appearing cortical grey matter away from major contusions. 
Region 7. The normal appearing white matter away from major contusions.
Regions 6 and 7 (grey and white matter) were composed of four sub-regions which 
showed no contusions. These were defined using the FA map rather than the ADC map, 
since this provided better discrimination of grey from white matter (as shown in figure 
24).
70
Methodological Developments
Figure 23. Regions of interest around the contusion. The area around the deep frontal 
contusion (white box) is copied in the three inset images. The pericontusional region 
(Region 3), the pericontusional hyperintensity (Region 4) and the hypointense rim (Region 
5) are outlined on the insets.
Figure 24. The FA map was used to develop the cortical grey and white matter regions of 
interest. Each region of interest was composed of four sub-regions of normal appearing 
grey and white matter respectively. Example regions of white matter (open black squares) 
and cortical grey matter (open white squares). Areas of contusion (white asterisk) were not 
included.
The seven regions were applied to the AADC maps and the median (50th centile), 2.5 
and 97.5 centile of AADC values in the seven regions were calculated for each patient. 
The 50th centile is defined as the AADC value below which 50% of the AADC values 
fell. This 50th centile is therefore a useful summary measure of the overall ADC change 
in the regions. The 2.5 and 97.5 centiles define the AADC value below which 2.5% and 
97.5% of the AADC values fell respectively. These were chosen as a measure of the 
more extreme ADC changes. It is important to emphasise that the 50th, 2.5 and 97.5
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centiles are absolute centiles for ADC changes in an individual patient. These centiles 
therefore are measures of ADC change in an individual in the absence of any 
intervention. Summary measures of these variables would therefore define the limits of 
change expected in a population of patients in the absence of any intervention.
These summary measurements were calculated as follows: For each region of interest 
the group mean and SD for the 50th, 2.5 and 97.5 centile AADC values were calculated. 
From the mean and SD the 99% confidence intervals of the mean 50th, 2.5 and 97.5 
centiles were calculated. These confidence intervals were calculated from the mean ± 
2.58 standard deviations. These confidence intervals describe the likely changes that can 
be attributed to test-retest variability in a population of head injured patients in the 
absence of any intervention. The 99% confidence intervals were chosen since the small 
sample size increases the risk of a type 1 statistical error (i.e. incorrectly concluding that 
a new individual differs significantly from the group) and wide confidence intervals help 
to reduce the risk of such an error. These data also allow the assessment of whether a 
AADC change due to an intervention is likely to be in excess of that attributed to test- 
retest variability.
5.23 Results
The spread of AADC value in each of the defined the regions are shown in the 
histograms below which plot the percentage of voxels in each region (on the y axis) that 
show values within a range of AADC bins (plotted on the x axis). Each set o f figures 
shows a family of histograms from individual patients. The tables beside each figure 
show the cut off AADC values, that define the 2.5, 50 and 97.5 centiles for the data, as 
the mean for the group as a whole, and the upper and lower 99% Cl for this mean 
(figures 25-31). When assessed across the whole brain the 2.5% and 97.5% cut off 
values of AADC represented changes from baseline ADC of 20-30%.
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Absolute AADC - All slices (region 1)
Histograms of AADC
3b
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0) 20 O)
-0* - 0.1 0.1 02 
AADC (x 10“3 m m 2/s  )
03 0.4
AADC
Centile
Mean
(n=6)
SD Upper 
99% Cl
Lower 
99% Cl
2.5 -0.218 0.067 -0.044 -0.392
50 0.009 0.024 0.071 -0.053
97.5 0.239 0.123 0.556 -0.078
Figure 25. The histogram plots of AADC values for all slices (region 1). Individual patient 
histograms (left) and the combined group histogram (right). The position of the mean 2.5th, 
50th and 97.5th centiles are shown. The histogram plots of are normalised for region 
volume such that the area under each curve is the same. The table shows the mean, SD, 
upper and lower 99% confidence intervals for the AADC centiles across all slices (region 1).
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Absolute ADC changes - Contused Slices (region 2)
Histograms of delta ADC
25
20
03
10 -
-02
A D C  d ifference (x 10-3  m m 2/s  )
-o.t 0.1
»-3
0.3 0.4
AADC
Centile
Mean
(n=6)
SD Upper 
99% a
Lower 
99% Cl
2.5 -0.206 0.072 -0.02 -0.392
50 0.006 0.023 0.064 -0.053
97.5 0.222 0.113 0.513 -0.069
Figure 26. The histogram plots of AADC values for contused slices (region 2). Individual 
patient histograms (left) and the combined group histogram (right). The position of the 
mean 2.5th, 50th and 97.5th centiles are shown. The histogram plots of are normalised for 
region volume such that the area under each curve is the same. The table shows the mean, 
SD, upper and lower 99% confidence intervals for the AADC centiles across the slices most 
clearly showing the contusions (region 2).
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Absolute ADC changes - Pericontusional Region (region 3)
H istogram s of de lta  A D C
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AADC
Centile
Mean
(n=6)
SD Upper 99% 
Cl
Lower 
99% Cl
2.5 -0.183 0.087 0.041 -0.407
50 0.001 0.017 0.044 -0.043
97.5 0.174 0.071 0.358 -0.01
Figure 27. The histogram plots of AADC values for the pericontusional region, as a whole 
(region 3). Individual patient histograms (left) and the combined group histogram (right). 
The position of the mean 2.5th, 50th and 97.5th centiles are shown. The histogram plots of 
are normalised for region volume such that the area under each curve is the same. The 
table shows the mean, SD, upper and lower 99% confidence intervals for the AADC centiles 
across the pericontusional region (region 3).
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Absolute ADC changes - Vasogenic Oedema (region 4)
Histogram s of de lta  A D C
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Mean
(n=6)
SD Upper 
99% Cl
Lower 
99% Cl
2.5 -0.249 0.141 0.115 -0.612
50 -0.03 0.062 0.13 -0.19
97.5 0.138 0.074 0.328 -0.052
Figure 28. The histogram plots of AADC values for the pericontusional vasogenic oedema 
seen as ADC hyperintensity (region 4). Individual patient histograms (left) and the 
combined group histogram (right). The position of the mean 2.5th, 50th and 97.5th centiles 
are shown. The histogram plots of are normalised for region volume such that the area 
under each curve is the same. The table shows the mean, SD, upper and lower 99% 
confidence intervals for the AADC centiles in the pericontusional vasogenic oedema (region
4).
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Absolute ADC changes - Hypointense Rim (region 5)
H istogram s of de lta  A D C
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99% Cl
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99% c i
2.5 -0.155 0.062 0.005 -0.315
50 -0.001 0.039 0.098 -0.101
97.5 0.151 0.06 0.305 -0.002
Figure 29. The histogram plots of AADC values for the pericontusional hypointense rim of 
tissue (region 5). Individual patient histograms (left) and the combined group histogram 
(right). The position of the mean 2.5th, 50th and 97.5th centiles are shown. The histogram 
plots of are normalised for region volume such that the area under each curve is the same. 
The table shows the mean, SD, upper and lower 99% confidence intervals for the AADC 
centiles in the pericontusional hypointense rim (region 5).
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Absolute ADC changes - Normal Appearing Grey Matter (region 6)
Histograms of delta ADC
© 20 O)
- 0.3 -0.2
A D C  d ifference (x 10-3  m m 2/s  )
- 0.1 0.1
r 3
0.2 0.4
AADC
Centile
Mean
(n=6)
SD Upper 
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Lower 
99% c i
2.5 -0.129 0.046 -0.01 -0.248
50) 0.012 0.012 0.043 -0.019
97.5 0.171 0.087 0.396 -0.053
Figure 30. The histogram plots of AADC values for the normal appearing grey matter 
(region 6). Individual patient histograms (left) and the combined group histogram (right). 
The position of the mean 2.5th, 50th and 97.5th centiles are shown. The histogram plots of 
are normalised for region volume such that the area under each curve is the same. The 
table shows the mean, SD, upper and lower 99% confidence intervals for the AADC centiles 
across the normal appearing grey matter (region 6).
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Absolute ADC changes - Normal Appearing White Matter (region 7)
H istogram s of d e lta  A D C
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AADC Mean SD Upper Lower
Centile (n=6) 99% CI 99% CI
2.5 -0.164 0.074 0.028 -0.355
50 -0.004 0.02 0.047 -0.055
97.5 0.142 0.086 0.364 -0.08
Figure 31. The histogram plots of AADC values for normal appearing white matter (region 
7). Individual patient histograms (left) and the combined group histogram (right). The 
position of the mean 2.5th, 50th and 97.5th centiles are shown. The histogram plots of are 
normalised for region volume such that the area under each curve is the same. The table 
shows the mean, SD, upper and lower 99% confidence intervals for the AADC centiles in 
the normal appearing white matter (region 7).
Finally it is useful to provide some idea of the magnitude of ADC change in relation to 
baseline values. In order to do this the fractional AADC (fAADC) was calculated for the 
whole volume of brain region 1 (figure 32).
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Fractional ADC changes - All slices (Region 1)
H istogram s of Fractional A D C  ch ang e
- 0.4 - 0.2
Fractional A D C  ch ang e
0.2 0.4 0.6
H istogram  of Fractional A D C  ch ang e
25
— Grouped data
>  15
£ io
- 0.2  0 0.2 
Fractional A D C  ch an g e
0.4 0.6
Figure 32. Individual (upper) and group (lower) histograms of fractional ADC change. The 
individual histograms are normalised for brain volume. The mean histogram for the patient 
group provides an idea of the changes in ADC relative to baseline for the study population 
as a whole. The dotted lines on the grouped histogram (lower) show that approximately 
three or four percent of voxels change by more that 0.2 (20%) of the baseline ADC value.
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HETROGENEITY BETWEEN REGIONS
The 99% confidence intervals for the 2.5 centile ADC change in the seven regions of 
interest are shown (Figures 33, 34 and 35).
99%  Confidence Intervals for the 2.5 centile of ADC change
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Figure 33. Confidence intervals for the 2.5 centile of AADC in the seven regions. The bar 
ends represent the 99% confidence limits. The bars all overlap each other.
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Figure 34. Confidence intervals for the 50th centile of AADC in the seven regions. The bar 
ends represent the 99% confidence limits. The bars all overlap each other.
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99% Confidence Intervals for the 97.5 centile of ADG change
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Figure 35. Confidence intervals for the 97.5 centile of AADC in the seven regions. The bar 
ends represent the 99% confidence limits. The bars all overlap each other.
The 99% confidence intervals of the mean 2.5, 50 and 97.5 centiles of ADC change 
(shown in figures 33, 34 and 35) all overlap. This demonstrates that the ADC variability 
was similar in all regions and supports the assumption that the test-retest reproducibility 
is broadly similar in the seven tissue regions. These data also provide limits for changes 
in the various percentiles of the ADC distribution that can be attributed to interscan 
variability.
5.2.4 Discussion
The test-retest variability of ADC measurements serves as a reference dataset against 
which results from other patients can be compared. This data also provide a context for 
assessing the significance of any ADC change in a group of patients undergoing a 
therapeutic intervention. The variability we have seen may differ from normal controls. 
The patients may have displayed increased ADC variability compared to normal controls 
because of their injuries or reduced variability because of their immobility in the scanner 
and relatively stable physiology. This consideration should be taken into account when if 
the data are used as a comparison to other groups of patients.
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53 The Validity of DWI for Assessing Changes in 
Diffusion.
53.1 Introduction
For reasons of speed and convenience, clinical application of the technique in acute 
stroke has generally relied on interpretation of diffusion weighted images rather than 
actual computation of ADC maps. These DWI are often acquired at only one b value 
(typically 1000 s/mm2).32 126 127 In many instances this approach is valid, and high signal 
intensity on DWI images is increasingly recognised as a usefiil imaging marker of acute 
ischaemic stroke. However the Stejskal-Tanner spin-echo sequences used in DWI 
sequences produces images which also have intrinsic T2 weighting. Consequently the 
interpretation of high signal intensity on DWI can be confounded by tissue with a long 
T2 (as occurs in subacute stroke due to vasogenic oedema). DWI in this situation shows 
high signal intensity which is not the consequence of restricted diffusion associated with 
cytotoxic oedema. This confounding effect may result in tissue with a high T2 
(classically resulting from late vasogenic oedema) to be misdiagnosed as showing 
cytotoxic oedema (classically resulting from early ischaemic cell swelling). This 
phenomenon is commonly tam ed “T2 shine through”.128'130 Calculation of the ADC 
map can avoid this confound. However, there is little recognition of the fact that changes 
in T2* properties of tissue may also be a significant confounder in this setting. 
Acquisition schemes for DWI typically utilize echo-planar imaging (EPI) and may 
inherently elicit substantial T2* contrast.85 Reductions in T2*, which may be the 
consequence of local haemoglobin desaturation or microhaemorrhages, reduce signal 
intensity on DWI and leads to the underdetection of cytotoxic oedema on DWI images. 
As with T2 shine through, this confound can be avoided by formal calculation of ADC. 
There are good physiological arguments to suggest that this phenomenon is important. 
Haemoglobin desaturation is commonly observed in ischaemic tissue, as oxygen 
extraction fraction increases to compensate for reductions in blood flow.131 When the 
infarction process is complete, oxygen extraction fraction falls, but during the process of 
evolving infarction, or in the presence of physiological heterogeneity, where small 
islands of compensated and decompensated tissue contribute to an imaged voxel.
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5.3.2 Results
We have termed this phenomenon “T2* shade back” and have observed it following 
head injury, where there may be reductions in ADC in regions that show little or no 
increase in intensity on raw DWI images (Figure 36 and 37). Perfusion imaging with 
PET shows perilesional hypoperfusion in these regions (Figure 38) suggestive of 
ischaemia.
FLAIR Im age
Figure 36. Co-registered images from left to right FLAIR, DWI (b=1000 sec/mm2 EPI 
acquisition), ADC map and T2* weighted image (DWI, b=0 sec/mm2 EPI acquisition)
FLAIR Im age DWI Im age 
(b 1000)
Figure 37. Detail from figure 36. Showing T2* dark back on T2* weighted image which can 
also be seen on DWI (co-localised open whiter arrowheads). Inspection of the area on DWI 
marked by the open white arrowhead, without consideration of T2* effects, would lead to 
the belief that diffusion in this area was increased whilst in fact the co-localised arrowhead 
on the ADC map shows the opposite. T2 shine-through is also present on the DWI where 
the ADC values are in fact normal, co-localised black arrowheads on the DWI and ADC 
map.
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FLAIR Image — CBF (ml/100g/min) —
Figure 38. Coregistered FLAIR and ,sO-PET CBF map showing significant pericontusional 
hypoperfusion extending beyond areas of pericontusional hyperintensity visible on the 
FLAIR image.
5.33 Discussion
These data show that there may be discrepancy between DWI and ADC measures in 
some regions where T2* changes result in signal degradation on DWI.
We have termed this phenomenon “T2* shade back”. We have observed these T2* 
shade back changes in patients following head injury, where regions of reduced ADC 
show little or no increase in intensity on raw DWI images, and perfusion imaging with 
PET shows perilesional hypoperfusion in these regions (Figure 38).
In the setting of head injury, the observed discrepancy may be due to ischaemia,7 or to 
microhaemorhages that are too small to be recognised on structural imaging.5 The T2* 
effects responsible for the phenomenon may be seen on gradient echo images with T2* 
weighting such as that obtained with EPI. The phenomenon is also likely to be important 
in other settings, such as acute stroke, where compensated ischaemia and haemoglobin 
desaturation may coexist with metabolic compromise and established infarction within a 
volume too small to be resolved by clinical imaging. A similar process has been cited as 
a possible mechanism for signal changes observed in the core of intracerebral 
haemorrhage,132 but the phenomenon has not, to our knowledge, previously been 
described in ischaemia. This observation clearly has relevance to the interpretation of 
DWI changes in ischaemia and also underlines the general need to understand the basis
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of signal changes in MRI in order to make rational inferences regarding underlying 
pathology.133
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5.4 Can FLAIR Assess Pericontusional Oedema?
5.4.1 Introduction
FLAIR images are CSF nulled and have T2 weighting (as described in section 2.1.2). 
Hyperintensity on FLAIR images is generally thought to reflect increased extracellular 
tissue water, or in the case of pathology, vasogenic oedema. Vasogenic oedema is 
thought to have a high ADC. If FLAIR hyperintensity were an accurate representation of 
high ADC, it might be possible to use this more widely available technique to provide a 
useful surrogate for tissue with a high ADC. However, no direct comparison has been 
undertaken, and the ADC characteristics of tissue which is hyperintense on FLAIR are 
unknown. By comparing coregistered FLAIR and ADC images the nature of the oedema 
in the FLAIR hyperintensity can be investigated.
5.4.2 Methods
Images were acquired using FLAIR and DWI sequences and coregistered as previously 
described in section 4.4. A qualitative assessment of the congruence between the FLAIR 
images and the calculated ADC maps was undertaken.
5.43 Results
Examination of the coregistered FLAIR image and ADC map revealed substantial 
differences between the two (see below). These large differences preclude the use of 
FLAIR as an adequate modality for defining vasogenic oedema and no quantitative 
assessments of the degree of discrepancy were made. Specifically the ADC values 
within FLAIR hyperintensity showed marked heterogeneity. ADC increases, reflecting 
vasogenic oedema, dominated around some contusions (Figure 39) and ADC decreases, 
typical of cytotoxic changes, were dominant in others (Figure 40). In some contusions a 
mixture of ADC increases and decreases were seen (Figure 41).
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Figure 39. FLAIR hyperintensity associated with increased ADC.values.
FLAIR (left) and ADC map (right) obtained at 3 Tesla from a patient 22 hours post head 
injury. The T2 hyperintensity in the left frontal contusion is associated with an increased 
ADC, typical of vasogenic oedema.
Figure 40. FLAIR hyperintensity associated with reduced ADC values
FLAIR (left) and ADC map (right) obtained at 3 Tesla from a patient 34 hours following 
head injury. The T2 hyperintensity in the left frontoparietal contusion is associated with 
a decreased ADC, typical of cytotoxic oedema.
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Figure 41. FLAIR hyperintensity associated with mixed ADC values
FLAIR (left) and ADC map (right) obtained at 3 Tesla from a patient 59 hours following 
head injury. The T2 hyperintensity in the large right sided contusion is associated with 
areas of both increased ADC (white arrowhead) and decreased ADC (black arrowhead). 
This heterogeneity of ADC, particularly within large contusions, was not uncommon.
5.4.4 Discussion
The example images (Figures 39 - 41) demonstrate hyperintensity on FLAIR cannot 
reliably predict the type of oedema which is present in the tissue. The coexistence of 
cytotoxic and vasogenic oedema within the FLAIR hyperintensity (as seen in figure 41) 
may be the result of two separate mechanisms of secondary damage, such as BBB 
disruption and ischaemia, or may reflect the same mechanism of damage at two stages 
during its evolution. In either case the importance of calculating the ADC map in 
understanding the pericontusional tissue is underlined.
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6 Characterising Contusional Injury
90
Characterising Contusional Injury
6.1 ROI Based Characterisation of ADC Images
6.1.1 Introduction
Earlier chapters have highlighted the possible advantages of using ADC maps to 
characterise pathophysiology following head injury. The clinician caring for head 
injured patients could use these imaging data to obtain insight into the amount and type 
of oedema which forms around head injuries. However, the preliminary analysis of ADC 
values around traumatic contusions suggested that there was substantial heterogeneity in 
the ADC appearances of these lesions. This chapter describes the pattern of ADC change 
around contusions and, since they may provided clues to the underlying physiology, the 
mechanisms involved in the formation o f these ADC changes are discussed.
The contusion and the surrounding tissue, termed the pericontusional region, has mixed 
composition. Contusions typically contain blood and blood breakdown products as well 
as injured brain tissue. The tissues in and around the contusion becomes swollen as 
oedema forms and inflammatory cells enter the tissue. The composition of individual 
contusions will vary and yet most contusions have a characteristic pattern. Contusions 
typically consist of a central core containing haematoma or haemorrhagic brain tissue 
and this core is surrounded by inflamed and swollen tissue.
On ADC maps the pattern is characteristic; contusions demonstrate a dark core of low 
diffusion surrounded by an area of increased diffusion which in turn is surrounded by a 
rim of reduced diffusion.1011 The terminology used in these referenced articles may 
require some clarification. The authors of these studies exclude the central haemorrhage 
from analysis and use the term “core” to describe the ADC hyperintensity around the 
haemorrhage. This contrasts with the of the term “core” in this thesis to define the 
central haemorrhage.
6.1.2 Methods
Patients were studied if they had sustained a head injury which was significant enough 
to require the mechanical ventilation. MRI scans were obtained on 30 patients and the 
ADC maps were constructed and analysed. Patient details are shown in table 6.1.
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No Age
(years)
Sex Mechanism 
of Injury
Hrs. from 
injury
GCS Marshall
Score
Apache II 
Score
ISS
1 41 M RTA 17 8 EML 16 25
2 27 M RTA 56 10 DI 2 13 16
3 56 M Fall 59 3 DI 3 16 29
4 41 M Fall 71 6 DI 3 16 43
5 27 M RTA 15 3 DI 4 19 27
6 21 F RTA 46 7 DI 2 14 26
7 40 M RTA 85 3 DI 3 18 38
8 39 M RTA 9 4 DI 2 25 21
9 31 F Fall 15 3 DI 2 18 9
10 29 M Fall 21 10 NEML 20 26
11 27 M Assault 15 4 NEML 28 27
12 00 M RTA 71 8 EML 15 16
13 17 M RTA 22 5 DI 3 18 32
14 22 M Assault 53 3 DI 2 21 16
15 70 F Fall 40 8 DI 2 19 16
16 20 M Assault 57 7 DI 4 11 16
17 38 M RTA 28 8 DI 2 16 10
18 19 M RTA 54 8 EML 18 25
19 20 M Assault 38 7 DI 3 20 16
20 52 F RTA 8 4 EML 24 49
21 23 M Assault 104 4 EML 11 26
22 37 M Fall 30 3 DI 2 15 25
23 46 M Fall 134 4 DI 3 20 25
24 32 M Assault 121 12 DI 4 5 9
25 57 M Fall 42 8 DI 4 18 48
26 38 F Fall 38 7 DI 4 15 27
27 30 M RTA 62 6 DI 3 19 30
28 41 F RTA 27 5 DI 2 19 21
29 18 M RTA 22 9 DI 3 13 14
30 35 M RTA 22 4 DI 3 23 25
Table 6.1. Patient characteristics for the analysis of pericontusional regions. Marshall 
score125 EML: evacuated mass lesion, NEML: non evacuated mass lesion, DI: diffuse injury 
score.
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To characterise the nature of the pericontusional regions four distinctive regions of 
interest were defined on each ADC image. The ADC values within these regions were 
then analysed. The composition of the tissue in these regions was explored by 
comparison to other imaging sequences.
These regions were:
Region 1. The haemorrhagic contusion core.
Region 2. The pericontusional hyperintensity surrounding the core 
Region 3. The hypointense rim of tissue beyond Region 2.
Region 4. An area of normal appearing brain away from the contusion.
An example of these four regions is shown in Figure 42.
In patients in whom more than one contusion was present, the regions were defined 
around the largest contusion in each subject. The analysis of one contusion from each 
patient ensured the independence of data. The four regions were outlined on the axial 
image slice where the selected contusion was largest and most apparent, the area and 
mean ADC within each region was then calculated. The brightness and contrast of the 
ADC images were standardised to provide a dynamic range between 4 and 10 x 1CT* 
mm2/sec. The four regions were manually outlined without knowledge of the time from 
injury to imaging. The region of normal brain was identified in the contralateral 
hemisphere avoiding structures such as the cerebral ventricles or obviously abnormality, 
this region was of constant shape, and contained contributions from grey and white 
matter in proportions that were broadly similar to the regions sampled in the contused 
hemisphere.
The ADC image analysis was performed using ImageJ software (ImageJ, NTH,
Bethesda, MD).
Comparison o f ADC with FLAIR and GRE
The appearances on coregistered FLAIR and GRE images were compared with the ADC 
maps in order to obtain insights into the pathology responsible for the imaging findings. 
However, since T l, T2 or T2* maps were not obtained no quantitative comparisons 
between these images and the ADC maps were made.
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6.1.3 Results
The relative areas of the four regions varied between individuals, however all sampled 
contusions showed the typical four regions. The mean ADC and area of each of the four 
regions are shown in is show in figures 42, 44 and table 6.2
Normal
Hypointense Rim
Vasogenic Oedema
04 06 09 10
Mean ADC (nvn'teec- < 10
Figure 42. The ADC map from a patient showing a left frontal contusion which 
demonstrates a contusional core (black arrowhead), pericontusional hyperintensity (white 
arrowhead) and hypointense rim (open arrowhead). The image on the right shows these 
regions outlined. The arrows connect the regions to the bar chart The bars indicate the 
mean ADC in these regions for the group of 30 patients and the 95% confidence intervals of 
the means are shown. The dotted line demonstrates the lower 95% confidence limit for the 
mean ADC in the normal regions. (n.b. There is a second smaller contusion visible in the 
right basal ganglia.)
All Patients
o;
OS 1
A DC (x 10-3 mm2/ s )
1.5
Figure 43
Histogram plots of ADC values in 
the four regions. These histograms 
represent combined data from the 
30 patients. The histograms are 
normalised for region size between 
individuals and between regions.
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Figure 44. Bar chart showing the mean area of each of the four regions from the 30 
patients. 95% confidence intervals are shown.
Area ± SD (mm2) ADC ± SD (mm2/sec x 10'3)
Region 1. (core) 114 ±90.0 0.603 ± 0.136
Region 2. (vasogenic oedema) 251 ± 138.7 0.963 ±0.25 *
Region 3. (hypointense rim) 187 ±91.7 0.591 ± 0.129 * t
Region 4. (normal tissue) 107 ±48.5 0.701 ±0.088 t
Table 6.2. The mean area and ADC of the four region of interest The values are means of 
the 30 values of the area and mean ADC in each region. * Significant difference in ADC 
compared to region 4. f  Significant difference in ADC compared to region 2.
While the relative size of different regions varied between subjects, it is noteworthy that 
the areas of the vasogenic oedema and hypointense rim were similar to each other, when 
compared to the area of the core. The mean areas of both the vasogenic oedema and the 
hypointense rim are significantly larger than the mean area of the core. Across all 30 
subjects, the combined mean area of the vasogenic oedema and hypointense rim was 
3.85 times the area of the core. This combined region may represent a “contusional 
penumbra” and a possible site of secondary ischaemic injury.
95
Characterising Contusional Injury
Region 1 (contusion core) had significantly lower mean ADC value when compared to 
region 4 (normal tissue) (p = 0.0013) and region 2 (vasogenic oedema) (p < 0.0001).
This core (region 1) was hypointense on GRE and FLAIR images. Region 2 (vasogenic 
oedema) had a significantly higher mean ADC value than the other three regions (p < 
0.0001). While this high ADC area generally co-localised to areas of high signal on 
FLAIR images, the concordance was not complete. In some regions the high ADC 
values co-localised with ‘normal’ tissue on FLAIR images and in other regions high 
intensity on FLAIR images co-localised to regions of relatively low ADC (Fig). In all 
subjects, the area of high ADC was surrounded by a small but consistent hypointense 
rim (region 3) where the ADC was significantly lower than in normal tissue (region 4) (p 
= 0.0006) and the vasogenic oedema (region 2); (p < 0.0001). The hypointense rim co­
localised with increased or normal signal intensity or FLAIR or GRE. These 
observations and the images in Figures 45 and 46 are presented to inform the reader 
about the typical ADC characteristics of regions defined using FLAIR and GRE images. 
The FLAIR and GRE images are not quantitative maps and therefore numerical data 
from these regions has not been obtained.
Figure 45. Coregistered image sets from a patient imaged 21 hours after injury. ADC image 
(left), FLAIR image (middle) and GRE image (right). A large left frontal contusion with a 
hypointense core is shown on all three image sequences, indicating the presence of 
haematoma. The hyperintensity surrounding these core regions is uniform on FLAIR 
images but of mixed density on the ADC images, this is a common finding and demonstrates 
that tissue with T2 hyperintensity may have heterogeneous diffusion characteristics. The 
hypointense rim of tissue outside this hyperintensity is seen on ADC but is absent on GRE, 
excluding haematoma as a cause of this hypointensity.
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Figure 46. Coregistered image sets from a patient ADC image (left), FLAIR image (middle) 
and GRE image (right). The left parietal contusion and right mid brain contusions show a 
hypointense core on all three image sequences. The hyperintensity surrounding the core 
regions is uniform on FLAIR and ADC images and demonstrates that, in this patient, the 
T2 hyperintensity is primarily due to vasogenic oedema. The hypointense rim of tissue 
outside this hyperintensity is seen on ADC but is absent on GRE, excluding haematoma as a 
cause of this hypointensity.
The area and ADC of each region was correlated against the interval between the injury 
and the MRI scan. The scatter plot of region area against time since injury is shown in 
Figure 47. The scatter plot of ADC against time since injury is shown in Figure 48.
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Figure 47. There was a significant correlation between area and time since injury in regions 
1 and 2 (p<0.05). The R2 value for this correlation is 0.29 in region 1 and 0.35 in region 2.
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Figure 48. There was a significant correlation between ADC and time since injury in 
regions 2 and 3 (p<0.05). The R2 value for the correlation is 0.23 in region 2 and 0.1 in 
region 3.
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6.1.4 Discussion
All contusions showed three pericontusional regions, a contusion core, an area of raised 
ADC around the core (pericontusional hyperintensity) and a thin hypointense rim. While 
some contusions showed these regions more clearly than others, this pattern was 
consistently present.
Imaging techniques often give new insight into pathophysiology of disease; in this case 
the ADC images may provide new information about the physiology of pericontusional 
tissues. The regions with low ADC values in the contusion core co-localised with low 
signal intensity lesions on T2 and T2* weighted images, obtained using FLAIR and 
GRE sequences, respectively (Figures 47 and 48). This concordance of imaging findings 
imply that these regions contain haemorrhage, or haemorrhagic contusion, a suggestion 
which is borne out by operative and post mortem findings.134 These findings are also 
concordant with those obtained in the first few hours and days following primary 
intracerebral haemorrhage, where low ADC values have been attributed to restricted 
diffusion within the microenvironment of the organised clot.132135
The pericontusional hyperintensity on ADC maps (region 2) and the quantitative 
measurement of high ADC values in these regions confirms that a dominant cause is the 
presence of highly diffusible water in vasogenic oedema.
The composition of the hypointense rim surrounding the zone of pericontusional oedema 
(region 3) is intriguing. The reduced ADC in these areas provides rigorous evidence of a 
change in diffusion behaviour. In the setting of ischaemic stroke, these low ADC values 
would be conventionally interpreted as providing evidence of ischaemic cytotoxic 
oedema, and this may provide one explanation for the finding. However, there is some 
evidence that extracellular oedema in these settings may have increased tortuousity.136 
This increase in tortuosity, possibly due to alterations in microarchitecture or protein 
content in the oedema fluid, may lead to reduced diffusion. The correct interpretation of 
this finding has important pathophysiological implications. If the reduction in ADC 
represents cytotoxic oedema, as seen after stroke, it would imply that the tissue is under 
significant ischemic burden. This region may therefore be an ischaemic penumbra after 
head injury and be an important site of secondary brain injury.
The area of the vasogenic oedema (region 2) showed a significant correlation with the 
time from injury. The area and ADC values of the hypointense rim also increased with
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time since injury, but to a lesser extent. This might imply that the hypointense rim exists 
at the edge of an expanding region of vasogenic oedema. This hypothesis would imply 
that ischaemia is a continuing process at the edge of a contusion; a process which 
continues for some days after injury.
The clinical relevance of these data may be that secondary injury continues for some 
days after injury. Therefore intensive care treatment of head injuries, particularly those 
patients in whom the hypointense rim is prominent, may need to be prolonged.
A potential source of bias, when considering the correlations between imaging findings 
time since injury, is that patients with larger contusions may have been less suitable for 
MRI scanning at early time points. This important point can only be effectively 
addressed by imaging the same patient at different time points. These sequential studies 
are planned.
It is important to emphasise that these findings highlight the issue of ongoing secondary 
ischaemic damage. The combined volume of the MRI characterised “contusional 
penumbra” was over three and a half times the volume of the contusion core. The use of 
ADC map findings may therefore allow us to rationally address the management this 
tissue.
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7 Metabolic Characterisation of ADC 
Changes
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7.1 Metabolic Correlates of DWI change defined by PET
7.1.1 Introduction
While DWI has been widely used in stroke, the metabolic correlates of regions with 
altered appearances on DWI remain unclear. The early literature suggested that DWI 
hyperintensity and ADC reductions represented cytotoxic oedema, which was thought to 
be irreversible. However, more recent reports have shown that such changes can be 
reversible. These findings suggest that DWI changes, even in the well studied setting of 
stroke, may reflect metabolically heterogeneous tissue, which may survive an insult or 
proceed to infarction. The situation in head injury is even less clear, both because of the 
paucity o f literature and the complexity o f pathophysiology. It is important to 
differentiate between these two categories of tissue, since the clinical judgements and 
scientific conclusions that are made would vary enormously in these two settings. We 
therefore undertook a comparison of pericontusional ADC changes with metabolic 
parameters derived from PET. These studies required PET and MRI to happen one after 
the other in order to minimise the effect of changing pathophysiology.
7.1.2 Methods
Nine patients who were eligible for study underwent imaging as soon as practically 
possible after injury, allowing for transfer, initial treatment and stabilisation on NCCU, 
assent from next o f kin and scanner availability. Patients initially underwent MRI before 
being transferred to PET. Every effort made to maintain stable physiology between and 
during the two scanning procedures. Patient characteristics are shown in table 7.1.
No. Age
(years)
Sex Mechanism 
ofInjury
Hr s. from 
injury
GCS Marshall
Score
Apache II 
Score
ISS
1 39 M RTA 9 4 DI2 25 21
2 29 M Fall 21 10 NEML 20 26
3 17 M RTA 22 5 DI3 18 32
4 38 M RTA 28 8 DI2 16 10
5 32 M Assault 121 12 DI4 5 9
6 38 F Fall 38 7 DI4 27
7 30 M RTA 62 6 DI3 19 30
8 18 M RTA 22 9 DI3 13 14
9 35 M RTA 22 4 DI3 23 25
Table 7.1. In all patients ADC map and FLAIR images were acquired and they then 
immediately underwent lsO-PET scanning. Maps of CBF, CBV, CMR02, and OEF were 
constructed from the PET data as described in Section 43.
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The five regions were outlined on the coregistered ADC map. (FLAIR) These regions 
were:
Region 1. An area of normal appearing brain away from the contusion.
Region 2. The entire pericontusional region (including core, vasogenic oedema, 
hypointense rim and a margin approximately 3 mm wide beyond this)
Region 3. The hypointense rim of tissue beyond the vasogenic oedema 
Region 4. The vasogenic oedema surrounding the core 
Region 5. The contusion core.
An example of these four regions is shown in Figure 50. The regions were then applied 
to the coregistered PET maps and the mean value of CBF, CBV, OEF and CMRO2 in 
these regions were calculated for each patient.
7.1.3 Results
Figure 49 shows an example of an ADC map with coregistered CBF and OEF maps 
from the PET study. Summary data for the metabolic variables calculated are shown 
(Figures 50 and 51) and listed in Table 7.2 and 7.3. While there were some significant 
differences in summary data between the different categories of tissue. However, it was 
noteworthy that there was enormous variability in metabolic characteristics within each 
physiological tissue compartment, and there was substantial overlap in the range of 
physiological characteristics of the different compartments defined using ADC maps. In 
particular CBF, CMR02,, CBV and OEF in the low ADC region was highly variable and 
clearly overlapped values seen in the “normal” region and those obtained for mixed 
grey/white regions of interest (ROI)s from healthy volunteers in our centre.
Figure 49. ADC map (left) showing left parietal contusion, CBF map (middle) with colour 
scale applied and OEF map (right) with colour scale applied. All images are coregistered to
0  - CBF (ml/100g/min) - 80 0  - OEF (ml/1 OOg/min) - 60
FLAIR.
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P e r ie o r r tu s io n a l :ontusional
Oedema
Means
(♦M SO)
Means
(+A1 SO)
CBF (ml/1 OOg/min)
Figure 50. ADC map with examples of the regions of interest (left), bar charts of mean CBF 
and OEF in these regions (middle and right). Note the ADC map shows an example of the 
regions in one patient The bars represent means from regions in all nine patients.
CBF (SD) P value OEF (SD) P value
Normal 36.9 (13.9) n/a 39.2 (9.3) n/a
Pericontusional 29.1 (15.4) 0.277 34.3(11.8) 0.339
Hypointense Rim 32.3 (16.2) 0.526 36.8 (13.4) 0.662
Vasogenic Oedema 28.0(19.2) 0.276 33.6(13.6) 0.318
Core 20.2(11.4) 0.013* 28.2 (15.2) 0.081
Table 7.2. Mean (SD) values of CBF (ml/1 OOg/min) and OEF (%). Significant differences 
from mean values in normal tissue (p<0.05) are indicated with an asterisk.
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Figure 51. ADC map with examples of the regions of interest (left), bar charts of mean (SD) 
CBV and CMR02 in these regions (middle and right). Note the ADC map shows an 
example of the regions in one patient The bars represent means from regions in all nine 
patients.
CBV (SD) P value CMR02 (SD) P value
Normal 4.1 (1.7) n/a 8.5 (3.2) n/a
Pericontusional 3.7 (1.3) 0.616 5.8 (2.2) 0.055
Hypointense Rim 3.4 (1.2) 0.384 6.4 (2.2) 0.133
Vasogenic Oedema 3.4 (1.8) 0.429 5.3 (3.1) 0.047*
Core 3.3 (1.5) 0.326 3.9 (2.8) 0.005*
Table 73. Mean (SD) values of CBV (ml/lOOg) and CMR02 (ml/lOOg/min). Significant 
differences from mean values in normal tissue (p<0.05) are indicated with an asterisk.
7.1.4 Discussion
These results describe the metabolic condition of the pericontusional regions seen on 
ADC maps. In this sample of nine patients the core region displayed significant 
reductions in CBF, OEF and CMRO2 . This region is likely to represent haematoma or 
haemorrhagic contusion as discussed in section 6.1.4. These changes in blood flow and 
metabolism in the core are therefore entirely understandable and the ADC reductions in 
this region are similar to those seen in intracerebral haematomas.132 135 The vasogenic 
oedema displayed reductions in CBF, CBV, OEF and CMR02; however of these only 
the CMRO2 was significantly reduced compared to normal tissue. These data suggest 
that if ischemia is causing a reduction in CMR02 in these regions it is not accompanied 
by an increase in OEF. Some studies have suggested microvascular compression as a 
physiological basis of such ischemia.8 In this situation the oxygen carried in the arterial 
blood is prevented from reaching the ischemic tissue by a diffusion barrier. This barrier 
leads to the oxygen not being extracted from the arterial blood and therefore OEF does 
not rise. The hypointense rim displayed non significant reductions in CBF, CBV, OEF 
and CMRO2 . These data do not support the view that the tissue in the hypointense rim is
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under significant ischaemic burden. There may however be small regions ischaemia 
within in the hypointense rim which are not sufficient to produce a significant increase 
in mean OEF or reduction in mean CMRO2 . The pericontusional region displayed non 
significant reductions in CBF, CBV, OEF and CMRO2 .
This region contains the other three regions (core, vasogenic oedema and hypointense 
rim) plus a further area of tissue outside these regions. The physiological values 
obtained in the pericontusional region will therefore be a weighted average of values 
from the tissues making up this pericontusional region. There are clear methodological 
reasons which may explain why the changes in physiology were heterogeneous and 
failed to reach significance. Firstly it must be acknowledged that the sample size was 
small and a type II statistical error may be present. Secondly while every effort was 
made to optimise the coregistration of images from PET and MRI there will always be 
some inaccuracies. This shortcoming is inevitable to some degree in any inter modality 
image comparison. Finally the in-plane resolution of PET maps was approximately 6mm 
and this may have been inadequate to accurately define the physiological values in some 
of the thin regions of pericontusional ADC change.
However, even accounting for these methodological issues, it appears that there may be 
significant physiological heterogeneity in tissue with homogeneous ADC characteristics. 
More specifically, some regions with ADC values which would normally be consistent 
with ischaemic cytotoxic oedema were associated with relatively normal CBF and 
CMRO2 and hence have a high probability of containing viable tissue. Similarly some 
areas of vasogenic oedema contained voxels with CMR02 values suggestive of critical 
ischaemia, possibly representing microvascular ischaemia. In any case, these data 
highlight the need to approach DWI analysis without preconceived ideas based on the 
findings in ischaemic stroke.
106
EM Correlates
8 Electron Microscopy Correlates
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8.1 Introduction
Pericontusional DWI changes may represent BBB breakdown, ischaemia or a 
combination of such changes. The DWI changes around cerebral contusions which were 
seen in two small human studies,1011 plus the DWI findings around intracerebral 
haemorrhage137 suggest that microvascular changes may be responsible for some 
secondary ischemic damage. Experimental data has shown that the imaging changes on 
T2 maps can distinguish necrosis and vasogenic oedema and these imaging findings 
correlate well with the histopathological location of such oedema.138 We obtained 
samples of pericontusional tissue on a separate set of seven patients undergoing surgery 
soon after head injury and concluded that electron microscopic o f this tissue may 
provide information about the origin of the early DWI changes around cerebral 
contusions head injury. Whilst the imaging finding associated with these tissue samples 
just prior to excision are unknown the EM images represent an attempt to understand the 
ultrastructural basis of the MR imaging findings that we observe.
8.1.1 Methods
ELECTRON MICROSCOPY
Pericontusional tissue obtained at the time o f surgery for space occupying lesions or 
refractory intracranial hypertension was fixed in 4% glutaraldehyde in 0.1 M PIPES 
buffer at pH 7.2, containing 0.3% hydrogen peroxide as an oxygen source to optimize 
the speed of fixation. After primary fixation for two hours, tissues were osmicated, bulk 
stained in uranyl acetate, dehydrated in ethanol and embedded in Spurr’s epoxy resin. 
Thin sections were further stained with lead citrate and uranyl acetate and viewed in a 
Philips CM 100 electron microscope (FEI Philips, Eindhoven, Holland) operated at 80 
kV. These data represent part of a bank of information used for correlation with 
imaging findings, and have been used to understand imaging findings in previous 
positron emission tomography (PET) studies,9 but have not previously been correlated 
with MRI. It is important to state that while I was involved in the collection of tissue 
samples and analysis of the electron microscopy images the electron microscopy was 
conducted by Dr J. Skepper in the Department of Anatomy in the University of 
Cambridge.
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8.1.2 Results
ELECTRON MICROSCOPY FINDINGS
Two of the seven samples of tissue were unsuitable for analysis after fixation. Tissue 
from the remaining five patients revealed extensive patchy perivascular oedema, with 
endothelial swelling resulting in microvascular obliteration. Inspection of electron 
microscopic images suggested an evolution of changes, as shown in Fig 52. Some 
samples (as shown in Fig 52a) showed a swollen basal lamina and endothelial swelling, 
but little overt perivascular oedema. Other samples (Fig 52b) additionally showed 
vacuolation of the basal lamina, and accumulation of perivascular oedema, which 
resulted in clefts between the astrocyte foot processes and the basal lamina. Finally, 
other tissue samples showed more oval vasogenic oedema (as seen in Figs 52c), with 
complete detachment of astrocyte foot processes from the microvessels. The lumen of 
many microvessels was obstructed, either due to endothelial swelling, and/or due to 
microvascular collapse. Adjacent neurons showed morphology of necrosis. These 
changes were consistent in all subjects, but varied in severity. The severity of 
ultrastructural abnormality was not related to time after injury.
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52a
Figure 52. Electron micrographs of pericontusional tissue showing evolution of pathology. 
Figure 52a shows a microvessel and associated pericyte (P) with a swollen basal lamina 
(solid arrow) and endothelial cell (E), but little overt perivascular oedema . The tissue in 
Figure 52b, obtained from a separate patient, additionally shows vacuolation of the basal 
lamina (solid arrow), and accumulation of perivascular oedema (asterisk). Finally, figure 
52c shows a microvessel with large separation of astrocyte foot processes (solid arrow) and, 
in other places, complete detachment (asterisk) of perivascular structures, from the 
microvessels. The lumen (L) of microvessels is obstructed, either due to endothelial swelling, 
debris, and/or due to microvascular collapse.
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8.1.3 Discussion
The ultrastructural findings in the tissue are not new but confirm data from other 
centres.59 60 However, they provide important insights into the pathophysiology 
underlying DWI changes. The samples of tissue obtained were exclusively from the 
margins of contusions at surgery. While the corresponding DWI imaging findings are 
unknown, it is highly likely that the samples represent tissue that would be included 
either in the region of high ADC surrounding the contusion core, or the transition from 
this region to the rim of tissue with low ADC values.
This tissue showed a range o f appearances, which do not systematically relate to time 
after injury. This is not altogether surprising, since lesions are likely to mature at 
different rates depending on the severity and location of injury, host factors, and the 
presence or absence of additional physiological insults such as hypoxia and hypotension. 
Further, the different samples are unlikely to have been obtained from strictly 
comparable locations in relation to distance from the contusion core, and may represent 
different phases of injury biology as pathophysiology expands in a dynamic fashion. 
However, it is possible to construct a plausible temporal sequence o f events based on the 
findings obtained. The brain in Fig 52a probably represents an early phase of the 
evolution o f these findings, with swelling of the basal lamina and endothelial cell, with 
small amounts o f perivascular oedema. In Fig 52b the endothelial swelling remains 
prominent, but there are visible vacuoles in the basal lamina. The astrocyte foot 
processes are clearly separated from the basal lamina by collection o f perivascular 
oedema. The tissue in Fig 52c represents overt vasogenic oedema, with large areas of 
freely diffusible fluid that would be expected to show high ADC values.
These appearances may delineate the structural changes that underpin pericontusional 
DWI changes early after head injury. The regions of low ADC in the peripheral rim of 
the lesion may contain tissue similar to that seen in Fig 52a. The increased water content 
in the swollen basal lamina and the endothelial swelling would represent environments 
with increased amounts of restricted water. Data obtained using PET and tissue pC>2 
monitoring suggests that the microvascular collapse that occurs as a consequence of 
endothelial swelling and perivascular oedema may cause tissue ischaemia.9 This may 
result in an additional cause of cytotoxic oedema in this setting. Further evolution of 
pathophysiology results in more overt vasogenic oedema (as seen in Figs 4b and 4c), 
with high ADC values, as seen in the immediate pericontusional region. It is plausible
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that vasoactive substances such as thrombin and inflammatory mediators released from 
the contusion core may provide the biological triggers for this sequence of events.139140
It appears that these regional variations in pathophysiology may provide snapshots of 
evolving injury in the traumatic penumbra surrounding contusions. However, there are 
clear limitations to the data. The most significant issue is the inability to robustly 
correlate imaging appearance with tissue. While there are substantial logistic and 
methodological difficulties in coregistering biopsy sites and preoperative imaging, this 
would be essential to conclusively establish the structural basis of imaging findings.
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9.1 Introduction
DWI is a widely used technique in acute stroke. This is by virtue of its ability to detect 
early ischaemic changes. This rapid detection of ischaemia raises the possibility that 
DWI may be used to investigate the effect of interventions on ischaemia after head 
injury.
The use of hyperventilation to control raised intracranial pressure is limited by concerns 
about cerebral vasoconstriction and ischaemia. This has created debate amongst 
clinicians about the safe use of hyperventilation after head injury as previously discussed 
in section 3.3. It has been suggested that a reduction in CMRO2 following 
hyperventilation would provide the strongest evidence of CBF reductions that resulted in 
critical ischaemia; i.e. of a magnitude that made it impossible to sustain the pre­
intervention level of oxygen metabolism. However, this approach is confounded by the 
finding that, when oxygen delivery is not a limiting factor, reductions in PaC02 have 
been shown to increase brain electrical activity and potentially CMRO2 . Given the 
heterogeneity of the CBF changes following head injury, this could mean that when data 
were averaged over a region, CMRO2 could be decreased, increased or unchanged, even 
when some parts of the region suffered reductions in CMRO2 . However, an increase in 
the extent (and/or intensity) of restricted diffusion following hyperventilation could 
provide conclusive evidence of new cytotoxic oedema.
In the context of relatively short imaging sessions (< 2 hours) such changes are only 
likely to be seen in tissue that is already compromised, and only just maintaining cellular 
metabolism. Such significantly compromised tissue does exist in the injured brain and 
data from our research group has previously demonstrated low brain tissue p 0 2 levels in 
regions where OEF is not critically high.9
These studies therefore were designed to assess the effect of a short period of 
hyperventilation on DWI changes in patients with head injury.
9.1.1 Methods
Nine patients underwent two DWI sequences during the same scanning session. The 
DWI sequences were separated by a mean of 43 minutes during which time the patients 
were hyperventilated. The hyperventilation was performed to test the experimental 
hypothesis and not because it was clinically indicated at the time. The hyperventilation 
produced a fall in mean PaC02 from 4.81kPa to of 3.55kPa (Table 9.1). A control group 
of six patients, who had also suffered severe head injury, underwent two DTI sequences
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without intervention The scans in the control group of patients were separated by 28 
minutes and the mean PaCC>2 change was 0.02kPa. The data from this control group 
were also presented in section 5.2 as part of the test-retest methodological development. 
Patient details for the two groups are shown in table 9.1. The need to limit imaging 
times to ~ 1 hour meant that it was impossible to acquire the test retest data as well as 
perform the hyperventilation intervention within individual patients.
The ADC maps were constructed for each of the two DWI scans in each patients. These 
ADC maps were coregistered to one another as described in the Image processing 
section (section 4.4). The change in ADC between the two scans was assessed by 
subtracting the first ADC map from the second ADC map to create the AADC map. (this 
process is described in more detail in the test-retest section (section 3.3) Regions of 
interest were developed from the first ADC map. The region were as follows:
Region 1. 
Region 2.
Region 3.
Region 4.
Region 5. 
Region 6.
Whole volume of brain (non-brain structures excluded).
Two or three slices which clearly demonstrate the contusion (non-brain 
structures excluded).
The whole pericontusional region on the slice most clearly showing the 
contusion. This region includes the core, the surrounding oedema and an 
area of tissue 3-4 mm wide beyond this.
The hyperintense vasogenic oedema surrounding the core of the 
contusion.
The hypointense rim of tissue lying just beyond the vasogenic oedema.
A normal area of mixed grey and white matter in the contralateral 
hemisphere (avoiding areas of contusion or ventricles)
The regions are illustrated in figures 53 and 54
Figure 53. Example of region 1. (left) and region 2. (right)
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Figure 54. Examples of regions 3, 4,5 and 6.
These six regions were applied to the AADC map for analysis. The overall change was 
assessed by defining the 50th centile AADC in each region. However, it was recognised 
that hyperventilation might result in changes that affected only a small proportion of 
voxels, without a significant change in summary values. Consequently, the extreme 
changes were assessed by defining the 2.5 and 97.5 centiles of AADC in each region. 
The effect of hyperventilation was assessed by comparison of these mean centile 
thresholds in each of these three categories in the intervention and non-intervention 
groups.
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Patients Age
(yrs)
Sex Mechanism 
ofInjury
Hrs.
from
Injury
GCS Marshall
Score
Apache II 
Score
ISS InterScan
Interval
(min)
CPP
(mmHg)
Baseline
ICP
(mmHg)
ICP
Change
(mmHg)
Baseline
c o 2
(kPa)
C02
Change
(kPa)
1 27 M RTA 15 3 DI 4 19 27 39 72 19 -1 4.71 -1.25
2 37 M Fall 30 3 DI 2 15 25 40 74 18 -2 4.5 -1.24
3 70 F Fall 40 8 DI 2 19 16 55 75 16 0 4.72 -1.57
gf 4 21 F RTA 46 7 DI 3 14 26 30 80 19 -2 5.03 -1.02
o3 5 20 M Assault 57 7 DI 4 11 16 35 67 24 -7 4.39 -1.11n
a 6 56 M Fall 59 3 EML 16 29 48 70 18 -1 4.52 -1.38
oP 7 40 M RTA 85 3 DI 2 18 38 50 71 21 -3 5.33 -1.16
8 29 M RTA 90 5 DI 2 13 50 40 79 9 0 4.39 -1.15
9 46 M Fall 134 4 DI 3 20 25 54 76 14 -2 5.71 -1.49
Mean
Median
38.4 61.7
4 16 26
43.4 73.7 17.5 -2.0 4.81 -1.26
10 52 F RTA 8 4 EML 24 49 17 78 7 0 4.21 -0.034OP 11 41 F RTA 27 5 DI 2 19 21 50 70 15 0 4.23 -0.08
BT
ST 12 19 M RTA 54 8 EML 19 25 25 70 22 -2 4.57 -0.02rw
3
1o'
13 30 M RTA 62 6 DI 3 19 30 20 78 15 1 4.71 0.11
14 41 M Fall 71 6 DI 3 16 43 17 73 26 -1 4.84 -0.05
p 15 36 M RTA 71 8 EML 15 16 39 71 21 2 4.91 -0.06
Mean
Median
p-value
36.50
0.807
48.8
0.465
6
0.151
19
0.186
27.5
0.812
28
*
0.018
73.3
0.839
17.6
0.969
0.0
*
0.030
4.5
0.295
0.02
*
<0.001
Table 9.1. Patient characteristics for the intervention analysis. Marshall score 125 EML: evacuated mass lesion, NEML: non evacuated mass lesion, DI: diffuse 
injury score. Means and medians shown for the intervention (upper) and non-intervention (lower) groups . Significant differences between the groups are shown by 
the p-values marked with an asterisk.
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9.1.2 Results
Patients in the two groups had similar demographics. However there was a significant 
difference in the interval from the first to second DWI scans (p=0.018). This interval 
was significantly shorter in the control group than in the intervention group. The degree 
of change in CO2 in the intervention group, while similar in all patients, was not 
constant, and was not associated with change in ICP. These are difficult factors to 
control in a clinical study of this kind. The mean PaC02 changed from 4.81kPa to 
3.55kPa, resulting in a significantly greater change (1.26 kPa) than in the control group 
(0.02 kPa; p<0.001). This degree of hyperventilation is similar to that used clinically in 
some centres. The volume of each region was similar in the two groups.
There was no significant difference in the median AADC values between the control and 
intervention groups in any of the six regions of interest, suggesting that the overall 
changes in ADC associated with hyperventilation were no more than that attributable to 
the variability of the technique (p > 0.05). Analysis of AADC cut off points for the 2.5th 
and 97.5th centile also showed no significant differences between the control and 
intervention groups (p > 0.05). When data from individual patients were considered, 
none showed a change in median AADC outside the 99% Cl for test-retest variability, as 
defined in section 3.3. However, individual ROIs in some subjects showed changes that 
fell outside these confidence intervals. While the statistical significance of these 
individual findings is difficult to interpret, it would appear that some regions (often the 
hypointense rim) may show further reductions in ADC with hyperventilation (Fig 55)
P re  h y p erve n tila tio n  A D C  P o s t h yp erven tila tio n  A D C
Figure 55. ADC maps pre hyperventilation (left) and post hyperventilation. Voxels with an 
ADC value below 0.55 x 10'3 mm2/sec are highlighted in red. The post hyperventilation ADC 
shows an increase in voxels below this threshold both around the contusion and in other 
diffuse areas.
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Figure 56. 56a. (upper) individual data, 56b.(lower) grouped data Normalised histograms 
of AADC values from the combined whole brain volume in the intervention and control 
groups.
AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -0.266 (0.055) -0.218 (0.067) 0.157
50 -0.002 (0.009) 0.009 (0.024) 0.409
97.5 0.280 (0.061) 0.239 (0.123) 0.289
Vol (ml) 943.34 (258.87) 993.39 (175.74) 0.81
Table 9.2. ADC changes (mm2/sec x KT4) in whole volume of brain following
hyperventilation.
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Histograms of ADC  differences -  grouped by intervention
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Figure 57b
Figure 57. 57a. (upper) individual data, 57b.(lower) grouped data .Normalised histograms 
of AADC values from the combined axial slices displaying the most obvious contusion for 
the intervention and control groups. Mean difference non significant (p>0.05).
AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -0.276 (0.067) -0.206 (0.072) 0.099
50 -0.002 (0.009) 0.006 (0.023) 0.724
97.5 0.289 (0.069) 0.222 (0.113) 0.195
Volume (ml) 210.17 (96.30) 220.54 (61.78) 0.91
Table 9 3 . ADC changes (mm2/sec x 10"4) in the contused slices following hyperventilation.
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Histograms of A DC differences -  grouped by intervention
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Figure 58b.
Figure 58. 58a. (upper) individual data, 58b.(lower) grouped data. Normalised histograms 
of AADC values from the combined pericontusional regions for the intervention and control 
groups. Mean difference non significant (p>0.05).
AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -0.301 (0.164) -0.183 (0.087) 0.157
50 -0.007 (0.015) 0.000 (0.017) 0.409
97.5 0.318 (0.197) 0.174 (0.071) 0.157
Volume (ml) 6.46 (3.15) 7.10 (2.04) 0.41
Table 9.4. ADC changes (mm2/sec x KT4) in the pericontusional region following
hyperventilation.
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Histograms of ADC differences -  grouped by intervention
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Figure 59. 59a. (upper) individual data, 59b.(lower) grouped data. Normalised histograms 
of AADC values from the combined regions of contusional oedema for the intervention and 
control groups. Mean difference non significant (p>0.05).
AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -0.358 (0.266) -0.249 (0.141) 0.409
50 -0.024 (0.046) -0.030 (0.062) 0.814
97.5 0.280 (0.194) 0.138 (0.074) 0.157
Vol (ml) 0.96 (0.56) 1.15 (0.79) 0.52
Table 9.5. ADC changes (mm2/sec x 10"4) in vasogenic oedema following hyperventilation.
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Histograms of ADC differences -  grouped by intervention
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Figure 60. 60a. (upper) individual data, 60b.(lower) grouped data. Normalised histograms 
of AADC values from the combined pericontusional hypointense rims for the intervention 
and control groups. Mean difference non significant (p>0.05).
AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -4.643 (13.412) -0.155 (0.062) 0.289
50 3.534 (10.576) -0.001 (0.038) 0.239
97.5 7.152 (20.681) 0.151 (0.060) 0.195
Vol (ml) 0.50 (0.13) 0.72 (0.32) 0.13
Table 9.6. ADC changes (mm2/sec x 10“*) in the hypointense rim following hyperventilation.
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AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -0.149 (0.043) -0.129 (0.046) 0.409
50 0.016 (0.020) 0.012 (0.012) 0.637
97.5 0.210 (0.060) 0.171 (0.087) 0.346
Vol (ml) 1.35 (0.46) 1.20 (0.17) 0.14
Table 9.7.ADC changes in grey matter following hyperventilation.
AADC Centile Intervention 
Mean AADC (SD)
Non Intervention 
Mean AADC (SD)
p-value
2.5 -0.192 (0.052) -0.164 (0.074) 0.409
50 0.013 (0.030) -0.004 (0.020) 0.157
97.5 0.241 (0.147) 0.142 (0.086) 0.126
Vol (ml) 1.18 (0.31) 1.18 (0.24) 1.00
Table 9.8. ADC changes (mm2/sec x lO-4) in white matter following hyperventilation.
9.1.3 Discussion
The changes in ADC with hyperventilation shown in this analysis are non-significant 
across the population of patients studied. While hyperventilation is known to reduce 
CBF in the injured brain these results suggest, within the limits of our sample size, no 
significant change in ADC following a brief period of moderate hyperventilation across 
the patient population. It is important to consider whether we may have missed changes 
either because of our experimental design or analysis techniques.
The centile thresholds used in these analyses were selected prospectively, and showed 
no overall significant changes. It is possible that significant differences may have been 
detected if we had selected other centile thresholds, but this would seem unlikely. This 
type of re-analysis would involve multiple comparisons, increasing the risk of a type 1 
statistical error or requiring a compensation for multiple comparisons. Clinical 
interpretation of a significant difference found by this type of post hoc data dredging 
would be difficult.
Inspection o f the histograms suggests there may be some systematic changes. These 
changes are best appreciated on the grouped data histograms (for instance figure 57b)
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where the intervention group has a greater spread of AADC values (both positive and 
negative changes of ADC). This spread may be due to a lower signal to noise ratio in the 
data from the intervention group or these findings may represent a real effect of 
hyperventilation on ADC values. If the effect is due to a real effect of hyperventilation 
the data suggest that there are both increases and decreases in ADC in the injured brain 
following hyperventilation. This interpretation would suggest that both cytotoxic and 
vasogenic oedema increase as a consequence of hyperventilation.
However there maybe some time bias in our data, since the intervention patients were 
studied before the control group. While the technique was (to the best of our knowledge) 
constant it is possible that the earlier (intervention) data was, for some reason, more 
“noisy” than our later (control) data, or some other bias may have occurred over time.
The lack of a significant change in ADC after hyperventilation should not reassure 
clinicians that hyperventilation is safe. It may be that we did not hyperventilate patients 
for long enough to induce significant ischaemia. The duration of hyperventilation used 
in these studies exceeded the 15-20 minute duration o f hyperventilation which has been 
shown to consistently produce significant increases in regional OEF in earlier PET 
studies from our group. However the duration and degree of hyperventilation may have 
been too short to produce ischaemia which could be seen as a change in ADC. Clinicians 
should therefore be cautious about extrapolating our results to support the safety of more 
prolonged periods of hyperventilation, since ischaemic burden is dependent on both the 
duration and severity of CBF reduction. It is important to note that other studies from 
our group have shown that CBF reductions, produced by hypocapnia in head injured 
patients, do not rapidly normalise and may even worsen over the first hour of 
hyperventilation. Finally, it must be acknowledged that our sample size was relatively 
small. The changes that we see in some patients with hyperventilation (Fig 55), while 
difficult to assess statistically, do not allow us to declare that the intervention is safe in 
all subjects.
9.1.4 Conclusion
The findings do not suggest that brief periods of hyperventilation after head injury cause 
ischaemia which is detectable as a change in ADC.
However due to the sample size and short duration o f hyperventilation we remain 
cautious about the safety of hyperventilation. Further, it appears that individual patients 
can show increases in the volume of brain with low ADC values (suggestive of 
ischaemia) following hyperventilation (for example see figure 55).
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10.1 Chapter Summaries
The data presented in this thesis represent a series of experiments conducted on severely 
head injured patients. The purpose of these studies was to gain insight into the process of 
secondary brain injury. However these studies are not easy to conduct; patient safety, 
coexisting injuries, physiological instability and the heterogeneity of patients are all 
significant obstacles. Theses obstacles must be either overcome, or at least 
accommodated, when undertaking such studies and when analysing the results.
In Chapter 3 the sensitivity of the brain to ischaemic injury and the formation of 
cytotoxic and vasogenic oedema was outlined. The data from experimental imaging 
studies after head injury have shown that DWI is capable of defining areas of vasogenic 
and cytotoxic oedema after head injury and that these areas show reduced perfusion. 
While animal data such as these are important, clinical studies are the only way of 
answering the question of how oedema and ischaemia interact in humans to produce 
secondary brain injury. Previous clinical studies after head injury have shown that 
vasogenic and cytotoxic oedema both occur around contusions, however these studies 
are small and generally observational. Importantly theses studies have not correlated 
these MRI findings with physiological evidence of ischaemia such as cerebral blood 
flow, metabolism and oxygen extraction.
In Chapter 5 methodological issues were examined.
Section 5.1 describes the testing of two infusion pumps in an MR environment as part of 
the development of the studies. Recommendations are made for the safe use of such 
equipment.
Section 5.2 reports the first data on the test-retest variability of ADC measurements. 
These data are important both as a general reference and also to provide a context for 
assessing the significance of any ADC change following a therapeutic intervention. 
Sections 5.3 demonstrates the effect of T2 shine through and T2* shade back on DWI. 
This underlines the importance of calculating ADC maps from DWI data.
Section 5.4 demonstrates the superiority o f ADC maps over FLAIR when defining 
vasogenic or cytotoxic oedema.
Chapter 6 describes the characteristic pattern of changes around contusions on ADC 
maps. These changes are corroborated with images obtained using FLAIR and GRE 
sequences to characterise the nature of the tissue present. The regions that were defined 
in these studies include a contusion core (with very low ADC values), an area of raised
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ADC around the core (pericontusional hyperintensity) and a thin rim of reduced ADC. 
The imaging findings suggest that the core consists of haemorrhage, or haemorrhagic 
contusion, and the pericontusional hyperintensity suggests the presence of vasogenic 
oedema. Inferences regarding the composition of the hypointense rim are more 
speculative but this region could represent ischaemic cytotoxic oedema and therefore be 
an important site of secondary injury. The area of the pericontusional hyperintensity 
showed a positive correlation with time from injury and this may reflect evolution of the 
secondary injury. The section concludes by making the point that the “contusional 
penumbra” is over three times larger than the contusion core. This clearly underlines the 
potential to improve clinical outcome if  this penumbral tissue can be salvaged by clinical 
interventions.
Chapter 7 describes the metabolic correlation of the pericontusional ADC changes.
These correlations were made using PET to obtain maps of CBF, OEF and CMRO2 In 
this sample of nine patients the core region (likely to represent haemorrhage), 
unsurprisingly displayed significant reductions in CBF, OEF and CMRO2 . The 
vasogenic oedema seen on ADC maps displayed a significant reduction in CMRO2 
compared to normal tissue, however CBF and OEF were not significantly reduced.
These data suggest that the pericontusional reduction in mean CMRO2 is not 
accompanied by an increase in mean OEF. This could be interpreted as demonstrating 
the lack of true ischaemia in these regions. However, microvascular compression may 
result in ischaemia despite apparently non-ischaemic values of CBF and OEF. This 
possibility is further discussed in section 8. The hypointense rim and entire 
pericontusional region displayed non significant reductions in CBF, CBV, OEF and 
CMR02. These data do not support the view that these tissue regions as a whole are 
under a significant ischaemic burden. It is important to remember that regional analysis 
may overlook very small areas of ischaemia which are not sufficient to produce a 
significant change in mean OEF or CMRO2 within the entire region. This section also 
discusses some methodological reasons why changes in physiology may have failed to 
reach significance.
Chapter 8 describes the EM findings in pericontusional brain tissue both as a correlate 
and possible explanation of the ADC changes after head injury. The patients had not 
undergone MRI prior to their surgery and it is therefore unknown what the MRI 
appearance o f this tissue would have been. The samples of tissue were however obtained 
exclusively from the margins of contusions and are likely to represent tissue from either 
areas of vasogenic oedema (ADC hyperintensity) or the hypointense rim seen on ADC
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maps. The EM images show a range of endothelial swelling and perivascular oedema. 
These findings are discussed in relation to the MRI and PET data presented previously. 
The particular the mechanisms by which this microvascular ischaemia may bring about 
secondary injury are outlined.
Chapter 9 presents the results of experiments investigating the dynamic nature of the 
pericontusional ADC changes after hyperventilation, a well known therapeutic 
intervention in head injured patients. Hyperventilation is a double edged sword after 
head injury, reducing ICP, but also reducing CBF and potentially producing ischaemia.
In these experiments PaCC>2 was reduced from a mean of 4.8 to 3.5kPa, a significant and 
clinically relevant reduction. These data showed no significant change in ADC across 
the study population, following a relatively brief period of hyperventilation, in any of the 
regions studied. This section discusses the potential reasons why a significant change in 
ADC after hyperventilation may have gone undetected. It should be concluded that 
while no significant ADC change could be detected these results do not demonstrate that 
routine hyperventilation is safe.
10.2Applicability of the Results to Patient Care
These studies considered the nature of pericontusional brain tissue. The research focused 
on the imaging findings; in particular the diffusion weighted MRI findings, but also the 
physiological parameters from PET. Imaging such as this will not be appropriate or 
available in most head injured patients in the UK for many years however these results 
allow the clinician to gain some generalisable insights. The volume of the 
pericontusional tissue has been shown to be large and associated with reduced blood 
flow and oxygen metabolism in some regions. The pericontusional swelling has been 
shown to be made of heterogenous regions each likely to be under different 
pathophysiological conditions
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11.1 Introduction
This research has highlighted the use of DWI, and particularly ADC map analysis, in the 
investigation of pericontusional changes after head injury. While this research has 
attempted to characterise the nature of the ADC changes there are further areas of 
investigation which are worth considering.
11.1.1 Sequential Imaging Studies
The temporal evolution of the ADC changes after human head injury is unknown. In 
section 6 the size of some of the pericontusional regions was associated with time from 
injury. However, since these patients were only imaged once, these associations could be 
due to a confounding variable or selection bias. Future studies should be undertaken to 
address the evolution of these changes. Sequential imaging of acute head injuries with 
DWI would avoid selection bias in the time of imaging. Such studies would address the 
change in the pericontusional regions over time.
11.1.2 Quantification of CBF & OEF with MRI
MRI techniques such as perfusion weighted imaging with contrast agents and arterial 
spin labelling14141 may allow CBF quantification using MRI. These techniques provide 
higher resolution than PET but their reliability is still debated.142 Their higher resolution 
combined with the ability to obtain intra-modality structural images, DWI and CBF 
maps would greatly assist the analysis of small regions. The quantification of OEF by 
MRI has also been reported however it is still a research technique. If OEF could be 
quantified with MRI, as with CBF, it would significantly assist analysis of regional 
physiology.
11.13 Localisation Of Structural Correlates
The EM images of pericontusional tissue offer a tantalising insight into the nature of 
ADC changes. However the appearance of this tissue on DWI is not known. The tissue 
samples are obtained at surgery from tissue which is removed for clinical reasons. The 
location of these samples on presurgical imaging is therefore unknown. There are likely 
to be significant logistical problems in accurately determining the location of the 
samples however this is essential if correlations are to be made between the imaging and 
EM appearance.
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11.1.4 Correlation Of DWI Changes With Clinical Outcome
Although a systematic attempt was made to obtain outcome data in the patients recruited 
to these studies, the overall numbers of patients was too small to allow useful 
correlations between the burden of ischaemia (as addressed by ADC restriction) and 
outcome. The recruitment of larger numbers of patients with early MR and late follow 
up would provide important information on the clinical significance of the changes that 
were observed.
11.1.5 Correlation Between Clinical Outcome And Overall Burden Of Axonal 
Injury
Diffusion weighted MR allows the construction of diffusion tensor images (DTI), which 
provide an excellent way of detecting and quantifying axonal injury. It would be 
possible to develop methods of quantifying the overall burden of axonal injury from 
such images. Correlation of such variables with clinical outcome would help to confirm 
the widely held view that diffuse axonal injury (rather than focal injury) may be the most 
important determinant of clinical outcome.
11.1.6 Correlation Of DWI Changes With Local Neuronal Outcome
While ischaemic injury is likely to be an important determinant of outcome, this effect 
will be substantially modulated by other influences such as age, extracranial injury, and 
comorbitity. Consequently, the correlations described in 10.1.4 would require relatively 
large numbers of patients. However, the biological significance of the DWI changes 
observed could be more easily studied by obtaining a readout of local neuronal survival. 
Follow up imaging with structural MRI (T2 weighted, FLAIR) shows that much of the 
high ADC lesion resolves with no residual abnormality. The fate of the low ADC rim 
remains ambiguous. However, structural MRI cannot detect selective neuronal loss. 
Techniques such as !H MR spectroscopy and nC-flumazenil PET can provide a more 
direct measure of local neuronal loss. These techniques represent an exciting way of 
understanding the outcome implications of local DWI changes.
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12.1 Appendix 1
12.1.1 Derivation of The Stejskal-Tanner Equation
Diffusion weighted imaging depends upon the irrecoverable phase shift which occurs 
with moving spins. The phase shift caused by the application o f a gradient field (along 
direction z in this example can be calculated by Equation 11:
£
(px — y j  Gzxdt = yGSzx 
o
Equation 11. y denotes the gyromagnetic ratio, G the gradient strength, h the gradient 
duration, 01 the phase shift of the spin transverse magnetization, and zl the spin position in 
z direction.
After the second pulse z2 is the spin position in direction z. With phase shift 
occurring between time A and A+8.
A+S
<p2 = y  fG z2dt = yGdz2
A
Equation 12. y denotes the gyromagnetic ratio, G the gradient strength, h the gradient 
duration, A the time interval between the pulses, 02 the phase shift of the spin transverse 
magnetization after the second gradient pulse, and Z2 the spin position in z direction
The resulting net dephasing (0>s) after the paired gradient pulses is therefore calculated 
by Equation 13:
<Ps=9i-9\=yGS{zx- z ^
Equation 13 From Equation 11 and 12. The net dephasing (0;) is given by subtracting the 
phase shift after the second gradient pulse (02) from the phase shift after the first gradient 
pulse (0i). Since the 180° refocusing pulse occurs between these two gradients, for static 
spins, the net dephasing should be zero (since zt = z2). However if the spins have moved (i.e. 
zi ^ z2) a net dephasing will occur.
It can be seen that for static spins, (molecules which do not diffuse) that zi=z2 and that 
the net dephasing (0>s) is therefore zero. For moving spins there is a net dephasing which 
reduces the transverse magnetization and therefore the signal.
This attenuation of the signal is given by the Stejskal Tanner Equation (Equation 14).
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Equation 14. Where Sb is the signal with the diffusion gradients applied, So the signal 
without diffusion effect, y denotes the gyromagnetic ratio, G the gradient strength, b the 
gradient duration, A the time interval between the pulses, D is the diffusion coefficient 
(which has dimensions of length2.time'1, usually given as mm2/sec).
and since the diffusion can be summarised by a constant (the b value) (Equation 15)
b = y 2G28 2 A
Equation 15. Where b is a summary constant of the gradient field strength and duration, y 
denotes the gyromagnetic ratio, G the gradient strength, b the gradient duration, A the time 
interval between the pulses
Equation 14. can therefore be simplified to the familiar form of the Stejskal-Tanner 
(Equation 16).
Sb = S 0e~bD
Equation 16. Where Sb is the signal with the diffusion gradients applied, So the signal 
without diffusion effect, b the constant summarising gradient strength and duration, D is 
the diffusion coefficient (which has dimensions of length2.time'1, usually given as mm2/sec).
12.1.2 The equation for fractional anisotropy
rA 73 Vfa -  Xf + fe  -  x)1 +
V2 + a2 + x]
Equation 17. Fractional anisotropy (FA). Where XI, 12,13 are the first, second and third 
eigen values and X is the mean diffusion. An FA of 0 describes isotropy (a spherical tensor) 
and an FA of 1 would be complete anisotropy (the tensor of FA = 1 would be an infinitely 
long tube).
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12.2 Appendix 2 -  Patient Characteristics
The 30 patients who underwent imaging studies were recruited between August 2002 
and May 2004. Three patients who were eligible for study were not enrolled because 
their relatives declined to give assent they were not studied and no data is kept on them. 
In addition one patient was enrolled but developed severe intracranial hypertension prior 
to imaging and who died before any studies could be performed. Details of this patient 
has not been included and no further data was kept on them.
Outcome data for the patients forms part of an ongoing study including, at least in some 
patients, repeat imaging studies however this data was not part of my work and is not 
therefore included in this manuscript. Whilst follow up data will be important for 
interpretation of the initial imaging findings the results of this ongoing study are not yet 
available.
Table of. patient characteristics for the 30 paients undergoing imaging. Marshall 
score125 EML: evacuated mass lesion, NEML: non evacuated mass lesion, DI: 
diffuse injury score
No Age
(years)
Sex
Mechanism 
of Injury
Hrs. from 
injury
GCS
Marshall
Score
Apache II 
Score
ISS
1 41 M RTA 17 8 EML 16 25
2 27 M RTA 56 10 DI 2 13 16
3 56 M Fall 59 3 DI 3 16 29
4 41 M Fall 71 6 DI 3 16 43
5 27 M RTA 15 3 DI 4 19 27
6 21 F RTA 46 7 DI 2 14 26
7 40 M RTA 85 3 DI 3 18 38
8 39 M RTA 9 4 DI 2 25 21
9 31 F Fall 15 3 DI 2 18 9
10 29 M Fall 21 10 NEML 20 26
11 27 M Assault 15 4 NEML 28 27
12 00 M RTA 71 8 EML 15 16
13 17 M RTA 22 5 DI 3 18 32
14 22 M Assault 53 3 DI 2 21 16
15 70 F Fall 40 8 DI 2 19 16
16 20 M Assault 57 7 DI 4 11 16
17 38 M RTA 28 8 DI 2 16 10
18 19 M RTA 54 8 EML 18 25
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19 20 M Assault 38
20 52 F RTA 8
21 23 M Assault 104
22 37 M FaU 30
23 46 M Fall 134
24 32 M Assault 121
25 57 M FaU 42
26 38 F FaU 38
27 30 M RTA 62
28 41 F RTA 27
29 18 M RTA 22
30 35 M RTA 22
7 DI 3 20 16
4 EML 24 49
4 EML 11 26
3 DI 2 15 25
4 DI 3 20 25
12 DI 4 5 9
8 DI 4 18 48
7 DI 4 15 27
6 DI 3 19 30
5 DI 2 19 21
9 DI 3 13 14
4 DI 3 23 25
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12.3 Appendix 3 APACHE II and Marshall scores
APACHE n  Score
The Acute Physiology And Chronic Health Evaluation II (APACHE II) scoring system 
is a widely used system for evaluating severity of illness. A higher score has been 
associated with worse outcome in a wide range of medical and surgical conditions. It 
takes the worst recorded variables in the first 24 hours of treatment and scores them as 
follows. The APACHE II score is the sum of points in the following 12 categories 
Age in years 
under 44 (0 points)
45-54 (2 points)
55-64 (3 points)
65-74 (5 points) 
over 74 (6 points)
History of severe organ insufficiency or immunocompromised?
Yes, and non-operative or emergency post-operative patient (5 points)
Yes, and elective post-operative patient (2 points)
No (0 points)
Rectal Temperature (Celsius)
over 40.9 (4 points)
39-40.9 (3 points)
38.5-38.9 (1 points)
36-38.4 (0 points)
34-35.9 (1 points)
32-33.9 (2 points)
30-31.9 (3 points) 
below 30 (4 points)
Mean arterial pressure (mmHg)
over 159 (4 points)
130-159 (3 points)
110-129 (2 points)
70-109 (0 points)
50-69 (2 points) 
below 50 (4 points)
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Heart rate (ventricular response)
over 179 (4 points)
140-179 (3 points)
110-139 (2 points)
70-109 (0 points)
55-69 (2 points)
40-54 (3 points) 
below 40 (4 points)
Respiratory Rate (non-ventilated or ventilated)
over 49 (4 points)
35-49 (3 points)
25-34 (1 points)
12-24 (0 points)
10-11 (1 points)
6-9 (2 points) 
below 6 (4 points)
Oxygenation (mmHg) (use Pa02 if Fi02 < 50%, otherwise use A-a gradient)
A-a gradient over 499 (4 points)
A-a gradient 350-499 (3 points)
A-a gradient 200-349 (2 points)
A-a below 200(if Fi02 over 49%) or p02 > than 70 (if Fi02 less than 50%) (0 points) 
p02 = 61-70 (1 points) 
p02 = 55-60 (3 points) 
p02 below 55 (4 points)
Arterial pH
over 7.69 (4 points)
7.60-7.69 (3 points)
7.50-7.59 (1 points)
7.33-7.49 (0 points)
7.25-7.32 (2 points)
7.15-7.24 (3 points) 
below 7.15 (4 points)
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Serum sodium (mMol/L)
over 179 (4 points)
160-179 (3 points)
155-159 (2 points)
150-154 (1 points)
130-149 (0 points)
120-129 (2 points)
111-119 (3 points) 
below 111 (4 points)
Serum potassium (mMol/L)
over 6.9 (4 points)
6-6.9 (3 points)
5.5-5.9 (1 points)
3.5-5.4 (0 points)
3-3.4 (1 points)
2.5-2.9 (2 points) 
below 2.5 (4 points)
Serum Creatinine (mg/100 mL)
over 3.4 and ACUTE renal failure (8 points)
2.0-3.4 and ACUTE renal failure (6 points) 
over 3.4 and chronic (4 points)
1.5-1.9 and ACUTE renal failure (4 points)
2.0-3.4 and chronic (3 points)
1.5-1.9 and chronic (2 points)
0.6-1.4 (0 points)
below 0.6 (2 points)
Hematocrit (%)
over 59.9 (4 points)
50-59.9 (2 points)
46-49.9 (1 points)
30-45.9 (0 points)
20-29.9 (2 points) 
below 20 (4 points)
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White blood count (total/cubic mm in 1000's)
over 39.9 (4 points)
20-39.9 (2 points)
15-19.9 (1 points)
3.0-14.9 (0 points)
1.0-2.9 (2 points) 
below 1.0 (4 points)
Glasgow Coma Scale Score
Points equal 15 minus the Glasgow Coma Scale Score 
Marshall Score (CT criteria)
The Marshall score is used to classify the severity of head injury based on the initial CT 
findings following head injury.
I: normal head CT scan
II (Diffuse Injury II): lesions, cisterns open, no shift
III (Diffuse Injury HI): cisterns effaced, no shift
IV (Diffuse Injury IV): Midline shift >5mm, no clot >25ml
V (EML): Evacuated mass lesion >25ml
VI (NEML): Non-evacuated mass lesion >25ml 
VII: lethal head injury
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